HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 49216,
"recordsTotal": 49216,
"next": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&ordering=days_late&start=48000",
"previous": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&ordering=days_late&start=47400",
"results": [
{
"registry_id": "NCT06447103",
"publication_url": "https://clinicaltrials.gov/study/NCT06447103",
"title": "89Zr-DFO-GmAb PET/CT vs Contrast-Enhanced CT for Detection of Recurrent Clear Cell Renal Cell Carcinoma After Surgery",
"has_exemption": false,
"start_date": "2024-08-06",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06739356",
"publication_url": "https://clinicaltrials.gov/study/NCT06739356",
"title": "North American Fetal Therapy Network Prospective Registry for Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia",
"has_exemption": false,
"start_date": "2025-03-04",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05766839",
"publication_url": "https://clinicaltrials.gov/study/NCT05766839",
"title": "A 2-Part, Open-Label, Phase 2, Multiple Dose Study to Evaluate the Pharmacodynamic Effects, Safety, and Tolerability of Patiromer in Children Under 12 Years of Age With Hyperkalaemia (EMERALD2)",
"has_exemption": false,
"start_date": "2025-04-06",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Vifor Pharma, Inc.",
"sponsor_slug": "vifor-pharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07166172",
"publication_url": "https://clinicaltrials.gov/study/NCT07166172",
"title": "North American Fetal Therapy Network Prospective Registry for Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia",
"has_exemption": false,
"start_date": "2025-06-23",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07483294",
"publication_url": "https://clinicaltrials.gov/study/NCT07483294",
"title": "Cerebellar-cortical Circuitry and Prediction of Treatment Response in Early Psychosis",
"has_exemption": false,
"start_date": "2025-11-01",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwell Health",
"sponsor_slug": "northwell-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07222215",
"publication_url": "https://clinicaltrials.gov/study/NCT07222215",
"title": "A Phase II Multi-Center Open-label Randomized Study of CAPecitabine in Combination With ELAcestrant Versus Capecitabine Alone in Advanced Estrogen Receptor-Positive Breast Cancer (CAPELA)",
"has_exemption": false,
"start_date": "2026-01-16",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Kristina A. Fanucci",
"sponsor_slug": "kristina-a-fanucci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07096778",
"publication_url": "https://clinicaltrials.gov/study/NCT07096778",
"title": "A Phase II, Open-Label, Multicenter Study of Inobrodib in Combination With Pomalidomide and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2026-01-22",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "CellCentric Ltd.",
"sponsor_slug": "cellcentric-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07502872",
"publication_url": "https://clinicaltrials.gov/study/NCT07502872",
"title": "TPG: a Phase 2 Trial of Polatuzumab Vedotin, Glofitamab, and Tafasitamab as Chemotherapy-sparing First-line Therapy for Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brown University",
"sponsor_slug": "brown-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07510607",
"publication_url": "https://clinicaltrials.gov/study/NCT07510607",
"title": "Assessing Metabolic Changes in Multiple Sclerosis Using Hyper-polarized Carbon 13 MRI",
"has_exemption": false,
"start_date": "2026-06-03",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Ari Green",
"sponsor_slug": "ari-green",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07296094",
"publication_url": "https://clinicaltrials.gov/study/NCT07296094",
"title": "Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder: A Double-Blind, Dose-Comparison Concurrent Control Randomized Trial",
"has_exemption": false,
"start_date": "2026-06-15",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06552000",
"publication_url": "https://clinicaltrials.gov/study/NCT06552000",
"title": "Phase 0 Trial of Pre-operative Tumor Treating Fields in Patients With Resectable Lung Cancer",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06854029",
"publication_url": "https://clinicaltrials.gov/study/NCT06854029",
"title": "Optimizing Long-Acting Pre-Exposure Prophylaxis and Medications for Opioid Use Disorder Interventions in Carceral Settings",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05479643",
"publication_url": "https://clinicaltrials.gov/study/NCT05479643",
"title": "A Pilot Study for a Novel and Personalized Voice Restoration Device for Patients With Laryngectomy",
"has_exemption": false,
"start_date": "2027-12-01",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05714839",
"publication_url": "https://clinicaltrials.gov/study/NCT05714839",
"title": "A Phase 1/2 Open-label, Multicentre, Dose Escalation and Expansion Study to Investigate the Safety, Tolerability, and Clinical Activity of Belantamab as Monotherapy and in Combination With Other Treatments in Participants With Multiple Myeloma",
"has_exemption": false,
"start_date": "2023-06-14",
"completion_date": "2029-12-03",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05130437",
"publication_url": "https://clinicaltrials.gov/study/NCT05130437",
"title": "A Phase 1/2, Global, Open-Label, Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study",
"has_exemption": false,
"start_date": "2021-11-09",
"completion_date": "2029-12-04",
"has_results": false,
"results_due": false,
"sponsor_name": "ModernaTX, Inc.",
"sponsor_slug": "modernatx-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06449651",
"publication_url": "https://clinicaltrials.gov/study/NCT06449651",
"title": "Double-blind, Randomized, Placebo-controlled Study Evaluating the Safety and Efficacy of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) in At-risk Pregnancies",
"has_exemption": false,
"start_date": "2024-11-11",
"completion_date": "2029-12-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07190248",
"publication_url": "https://clinicaltrials.gov/study/NCT07190248",
"title": "A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084 in Combination With Subcutaneous Pembrolizumab and Berahyaluronidase Alfa (MK-3475A) Versus MK-3475A in Combination With Pemetrexed/Platinum (Carboplatin or Cisplatin) Chemotherapy as First-line Treatment of Participants With KRAS G12C-Mutant, Advanced or Metastatic Nonsquamous NSCLC (KANDLELIT-007)",
"has_exemption": false,
"start_date": "2025-10-08",
"completion_date": "2029-12-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07623161",
"publication_url": "https://clinicaltrials.gov/study/NCT07623161",
"title": "A Phase 3, Double-Blind, Randomized Trial Evaluating the Efficacy and Safety of Elritercept (TAK-226) Compared to Placebo in Participants With Myelofibrosis and Anemia on Concurrent Ruxolitinib Therapy",
"has_exemption": false,
"start_date": "2026-08-25",
"completion_date": "2029-12-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04938817",
"publication_url": "https://clinicaltrials.gov/study/NCT04938817",
"title": "A Phase 1b/2 Study to Evaluate the Efficacy and Safety of Investigational Agents as Monotherapy or in Combination With Pembrolizumab for the Treatment of Participants With PD-1/L1-refractory Extensive-Stage Small Cell Lung Cancer in Need of Second-Line Therapy (KEYNOTE-B98)",
"has_exemption": false,
"start_date": "2021-08-19",
"completion_date": "2029-12-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06804642",
"publication_url": "https://clinicaltrials.gov/study/NCT06804642",
"title": "Rehabilitation of Locomotor Function in Parkinson's Disease by Non-invasive Spinal Cord Stimulation",
"has_exemption": false,
"start_date": "2024-12-12",
"completion_date": "2029-12-11",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Louisville",
"sponsor_slug": "university-of-louisville",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06747949",
"publication_url": "https://clinicaltrials.gov/study/NCT06747949",
"title": "A Multicenter, Open-Label, Long-term, Extension Study to Evaluate the Safety and Tolerability of Dazodalibep in Participants With Sjögren's Syndrome (SS)",
"has_exemption": false,
"start_date": "2025-02-25",
"completion_date": "2029-12-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07508982",
"publication_url": "https://clinicaltrials.gov/study/NCT07508982",
"title": "Phase1b/2 Trial Of AZA + APG1252 In Patients With High-Risk AML",
"has_exemption": false,
"start_date": "2026-05-22",
"completion_date": "2029-12-12",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07544654",
"publication_url": "https://clinicaltrials.gov/study/NCT07544654",
"title": "A Phase III, Multi-center, Open-label, Randomised, Controlled Trial of Intravenous Obrixtamig in Combination With Carboplatin and Etoposide vs. Carboplatin and Etoposide as First-line Therapy in DLL3-positive Patients With Unresectable Locally Advanced or Metastatic Extrapulmonary Neuroendocrine Carcinomas",
"has_exemption": false,
"start_date": "2026-06-15",
"completion_date": "2029-12-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07064473",
"publication_url": "https://clinicaltrials.gov/study/NCT07064473",
"title": "EASi-PROTKT™ - A Phase III Double-blind, Randomised, Parallel-group Superiority Trial to Evaluate Efficacy and Safety of the Combined Use of Oral Vicadrostat (BI 690517) and Empagliflozin Compared With Placebo and Empagliflozin in Participants With Type 2 Diabetes, Hypertension and Established Cardiovascular Disease",
"has_exemption": false,
"start_date": "2025-07-22",
"completion_date": "2029-12-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06677060",
"publication_url": "https://clinicaltrials.gov/study/NCT06677060",
"title": "A Phase III, Randomised, Placebo-controlled, Event-driven Study to Evaluate the Effect of Baxdrostat in Combination With Dapagliflozin Compared With Dapagliflozin Alone on the Risk of Incident Heart Failure and Cardiovascular Death",
"has_exemption": false,
"start_date": "2025-03-14",
"completion_date": "2029-12-17",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06742723",
"publication_url": "https://clinicaltrials.gov/study/NCT06742723",
"title": "A Phase III, Randomised, Double-blind, Placebo-controlled, Event-driven Study to Assess the Efficacy, Safety and Tolerability of Baxdrostat in Combination With Dapagliflozin Compared With Dapagliflozin Alone on Renal Outcomes and Cardiovascular Mortality in Participants With Chronic Kidney Disease and High Blood Pressure",
"has_exemption": false,
"start_date": "2025-03-03",
"completion_date": "2029-12-18",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07288567",
"publication_url": "https://clinicaltrials.gov/study/NCT07288567",
"title": "A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (13 to 17 Years of Age)",
"has_exemption": false,
"start_date": "2026-01-29",
"completion_date": "2029-12-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07286058",
"publication_url": "https://clinicaltrials.gov/study/NCT07286058",
"title": "A Phase 3, Multicenter, Long-Term Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of Zasocitinib (TAK-279) in Subjects With Active Psoriatic Arthritis Who Are Either Biologic DMARD-Naïve or Biologic DMARD-Experienced, Including Those With Inadequate Response to Biologic DMARDs",
"has_exemption": false,
"start_date": "2026-03-11",
"completion_date": "2029-12-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07579429",
"publication_url": "https://clinicaltrials.gov/study/NCT07579429",
"title": "Research On Nicotinamide Riboside Supplement Support in MDS (ROSS Trial)",
"has_exemption": false,
"start_date": "2026-05-20",
"completion_date": "2029-12-18",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03684018",
"publication_url": "https://clinicaltrials.gov/study/NCT03684018",
"title": "Randomized Study of Two Dose Levels of Privigen in Pediatric CIDP",
"has_exemption": false,
"start_date": "2019-02-28",
"completion_date": "2029-12-20",
"has_results": false,
"results_due": false,
"sponsor_name": "CSL Behring",
"sponsor_slug": "csl-behring",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04684368",
"publication_url": "https://clinicaltrials.gov/study/NCT04684368",
"title": "A Phase 2 Trial of Chemotherapy Followed by Response-Based Whole Ventricular &Amp; Spinal Canal Irradiation (WVSCI) for Patients With Localized Non-Germinomatous Central Nervous System Germ Cell Tumor",
"has_exemption": false,
"start_date": "2021-07-13",
"completion_date": "2029-12-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06907147",
"publication_url": "https://clinicaltrials.gov/study/NCT06907147",
"title": "Global Pilot Study of rEnal and Hepatic coMbINed denervatIon in Subjects With Uncontrolled Hypertension With and Without High Cardiovascular Risk",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2029-12-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Medtronic Vascular",
"sponsor_slug": "medtronic-vascular",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05844982",
"publication_url": "https://clinicaltrials.gov/study/NCT05844982",
"title": "A Trial Evaluating Intravitreal Faricimab (6.0 mg) Injections or Fluocinolone Acetonide (0.19 mg Intravitreal Implants vs Observation for Prevention of Visual Acuity Loss Due to Radiation Retinopathy",
"has_exemption": false,
"start_date": "2023-11-21",
"completion_date": "2029-12-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Jaeb Center for Health Research",
"sponsor_slug": "jaeb-center-for-health-research",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07459504",
"publication_url": "https://clinicaltrials.gov/study/NCT07459504",
"title": "A Sequential Multiple Assignment Randomized Trial of Diet Treatments for Hepatic Steatosis and Cardiometabolic Risk in Youth",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2029-12-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Michigan State University",
"sponsor_slug": "michigan-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04924075",
"publication_url": "https://clinicaltrials.gov/study/NCT04924075",
"title": "A Phase 2 Study to Evaluate the Efficacy and Safety of Belzutifan (MK-6482, Formerly PT2977) Monotherapy in Participants With Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Advanced Solid Tumors With HIF-2α Related Genetic Alterations",
"has_exemption": false,
"start_date": "2021-08-12",
"completion_date": "2029-12-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06716606",
"publication_url": "https://clinicaltrials.gov/study/NCT06716606",
"title": "An Open Label Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD)",
"has_exemption": false,
"start_date": "2024-12-12",
"completion_date": "2029-12-27",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06357533",
"publication_url": "https://clinicaltrials.gov/study/NCT06357533",
"title": "A Phase III, Randomised, Open-label, Global Study of Datopotamab Deruxtecan (Dato-DXd) in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Pembrolizumab Monotherapy for the First-line Treatment of Participants With Locally-advanced or Metastatic Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations (TROPION-Lung10)",
"has_exemption": false,
"start_date": "2024-04-11",
"completion_date": "2029-12-28",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07444567",
"publication_url": "https://clinicaltrials.gov/study/NCT07444567",
"title": "ROSY-F: Roll-Over Study for Participants Who Have Completed a Previous Study With Benralizumab (Fasenra) and Are Judged by the Investigator to Clinically Benefit From Continued Treatment",
"has_exemption": false,
"start_date": "2026-05-25",
"completion_date": "2029-12-28",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03458429",
"publication_url": "https://clinicaltrials.gov/study/NCT03458429",
"title": "Safety and Efficacy of GMFFP From Young Healthy Donors (18-35), Treated With G-CSF to Ameliorate Frailty and Enhance the Immune Risk Profile in Older Individuals",
"has_exemption": false,
"start_date": "2018-02-05",
"completion_date": "2029-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Dipnarine Maharaj",
"sponsor_slug": "dipnarine-maharaj",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05910801",
"publication_url": "https://clinicaltrials.gov/study/NCT05910801",
"title": "Tafasitamab, Lenalidomide and Venetoclax Combination Therapy for Relapsed or Refractory Mantle Cell Lymphoma (V-MIND): a Phase II Study with Safety Lead-In",
"has_exemption": false,
"start_date": "2024-01-04",
"completion_date": "2029-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Academic and Community Cancer Research United",
"sponsor_slug": "academic-and-community-cancer-research-united",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06764615",
"publication_url": "https://clinicaltrials.gov/study/NCT06764615",
"title": "A Phase 2, Open-Label Extension Trial to Evaluate the Long-term Safety and Tolerability of Oral Zasocitinib (TAK-279) in Participants With Moderately to Severely Active Ulcerative Colitis and Moderately to Severely Active Crohn's Disease",
"has_exemption": false,
"start_date": "2025-05-28",
"completion_date": "2029-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05569486",
"publication_url": "https://clinicaltrials.gov/study/NCT05569486",
"title": "Elucidating the Central Mechanism(s) of Action for Green Light Therapy in Managing Chronic Pain",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2029-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Arizona",
"sponsor_slug": "university-of-arizona",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00262470",
"publication_url": "https://clinicaltrials.gov/study/NCT00262470",
"title": "Treatment of Orthostatic Intolerance",
"has_exemption": false,
"start_date": "1997-04-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Satish R. Raj",
"sponsor_slug": "satish-r-raj",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT00900497",
"publication_url": "https://clinicaltrials.gov/study/NCT00900497",
"title": "A Phase I/II Study For the Use of White Blood Cells From Healthy Donor-participants To Treat Subjects With Solid Cancers",
"has_exemption": false,
"start_date": "2009-04-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Dipnarine Maharaj",
"sponsor_slug": "dipnarine-maharaj",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01841723",
"publication_url": "https://clinicaltrials.gov/study/NCT01841723",
"title": "A Multicenter Phase 2 Study of the Bruton's Tyrosine Kinase Inhibitor PCI-32765 (Ibrutinib) for Treatment of Relapsed Hairy Cell Leukemia",
"has_exemption": false,
"start_date": "2013-04-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02582697",
"publication_url": "https://clinicaltrials.gov/study/NCT02582697",
"title": "Phase 3 Accelerated BEP: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours",
"has_exemption": false,
"start_date": "2014-02-28",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Sydney",
"sponsor_slug": "university-of-sydney",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06984757",
"publication_url": "https://clinicaltrials.gov/study/NCT06984757",
"title": "Mid-frontal Delta/Theta and Cognitive Control",
"has_exemption": false,
"start_date": "2017-09-25",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nandakumar Narayanan",
"sponsor_slug": "nandakumar-narayanan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03373968",
"publication_url": "https://clinicaltrials.gov/study/NCT03373968",
"title": "Open Label, Long-term Safety, Tolerability, and Efficacy Study of GIVINOSTAT in All DMD Patients Who Have Been Previously Treated in One of the GIVINOSTAT Studies",
"has_exemption": false,
"start_date": "2017-10-24",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Italfarmaco",
"sponsor_slug": "italfarmaco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03998527",
"publication_url": "https://clinicaltrials.gov/study/NCT03998527",
"title": "Non-Invasive Spinal Cord Stimulation and Respiratory Plasticity",
"has_exemption": false,
"start_date": "2018-05-17",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Louisville",
"sponsor_slug": "university-of-louisville",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03599765",
"publication_url": "https://clinicaltrials.gov/study/NCT03599765",
"title": "External Beam Radiation to Eliminate Nominal Metastatic Disease (EXTEND): A Randomized Phase II Basket Trial Assessing the Efficacy of Upfront Local Consolidative Therapy (LCT) for Oligometastatic Disease",
"has_exemption": false,
"start_date": "2018-07-31",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03683251",
"publication_url": "https://clinicaltrials.gov/study/NCT03683251",
"title": "A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Portal)",
"has_exemption": false,
"start_date": "2018-09-20",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03919292",
"publication_url": "https://clinicaltrials.gov/study/NCT03919292",
"title": "Phase 1/2 Study of Neratinib and Divalproex Sodium (Valproate) in Advanced Solid Tumors, With an Expansion Cohort in Ras-Mutated Cancers",
"has_exemption": false,
"start_date": "2019-05-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Virginia Commonwealth University",
"sponsor_slug": "virginia-commonwealth-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03474029",
"publication_url": "https://clinicaltrials.gov/study/NCT03474029",
"title": "Six Weeks of Daily Rifapentine vs. a Comparator Arm of 12-16 Week Rifamycin-based Treatment of Latent M. Tuberculosis Infection: Assessment of Safety, Tolerability and Effectiveness",
"has_exemption": false,
"start_date": "2019-08-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Centers for Disease Control and Prevention",
"sponsor_slug": "centers-for-disease-control-and-prevention",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03937635",
"publication_url": "https://clinicaltrials.gov/study/NCT03937635",
"title": "Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)",
"has_exemption": false,
"start_date": "2019-09-16",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03911700",
"publication_url": "https://clinicaltrials.gov/study/NCT03911700",
"title": "Prospective, Multi-Center, Open-Label, Randomized, Controlled Trial of Phasix™ Mesh to Prevent Incisional Hernia Subsequent to Open Midline Laparotomy",
"has_exemption": false,
"start_date": "2019-12-12",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "C. R. Bard",
"sponsor_slug": "c-r-bard",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04166318",
"publication_url": "https://clinicaltrials.gov/study/NCT04166318",
"title": "A Randomized Phase II Study of De-Intensified ChemoRadiation for Early-Stage Anal Squamous Cell Carcinoma (DECREASE)",
"has_exemption": false,
"start_date": "2020-01-02",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03971799",
"publication_url": "https://clinicaltrials.gov/study/NCT03971799",
"title": "Phase 1/2 Study of Anti-CD33 Chimeric Antigen Receptor-Expressing T Cells (CD33CART) in Children and Young Adults With Relapsed/Refractory Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2020-01-08",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Center for International Blood and Marrow Transplant Research",
"sponsor_slug": "center-for-international-blood-and-marrow-transplant-research",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04516135",
"publication_url": "https://clinicaltrials.gov/study/NCT04516135",
"title": "A Randomized Phase II Trial of Palliative Pelvic Radiation Therapy to Improve Health Related Quality of Life in Gynecologic Malignancies",
"has_exemption": false,
"start_date": "2021-01-11",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04661358",
"publication_url": "https://clinicaltrials.gov/study/NCT04661358",
"title": "A Randomized Clinical Trial Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening",
"has_exemption": false,
"start_date": "2021-03-05",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jaeb Center for Health Research",
"sponsor_slug": "jaeb-center-for-health-research",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04474847",
"publication_url": "https://clinicaltrials.gov/study/NCT04474847",
"title": "A Randomized Double-Blind, Placebo Controlled Trial of Abatacept (CTLA4-Ig) in Giant Cell Arteritis (ABAGART)",
"has_exemption": false,
"start_date": "2021-03-29",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04774159",
"publication_url": "https://clinicaltrials.gov/study/NCT04774159",
"title": "Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk: A Randomized Trial",
"has_exemption": false,
"start_date": "2021-05-06",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Population Health Research Institute",
"sponsor_slug": "population-health-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05099770",
"publication_url": "https://clinicaltrials.gov/study/NCT05099770",
"title": "A Phase 3 Randomized Controlled Study of Renal Autologous Cell Therapy (REACT) in Subjects With Type 2 Diabetes and Chronic Kidney Disease (REGEN-006)",
"has_exemption": false,
"start_date": "2022-01-05",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Prokidney",
"sponsor_slug": "prokidney",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05183646",
"publication_url": "https://clinicaltrials.gov/study/NCT05183646",
"title": "A Pivotal Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of DMX-200 in Patients With Focal Segmental Glomerulosclerosis (FSGS) Who Are Receiving an Angiotensin II Receptor Blocker (ARB)",
"has_exemption": false,
"start_date": "2022-05-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Dimerix Bioscience Pty Ltd",
"sponsor_slug": "dimerix-bioscience-pty-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06946264",
"publication_url": "https://clinicaltrials.gov/study/NCT06946264",
"title": "Characterization of Bronchodilator Response in Children With Bronchiolitis Using Phenotypic and Genotypic Features",
"has_exemption": false,
"start_date": "2022-07-08",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nemours Children's Clinic",
"sponsor_slug": "nemours-childrens-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05409066",
"publication_url": "https://clinicaltrials.gov/study/NCT05409066",
"title": "A Phase 3, Open-Label Study to Evaluate Safety and Efficacy of Epcoritamab in Combination With Rituximab and Lenalidomide (R2) Compared to R2 in Subjects With Relapsed or Refractory Follicular Lymphoma (EPCORE FL-1)",
"has_exemption": false,
"start_date": "2022-09-20",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Genmab",
"sponsor_slug": "genmab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05527340",
"publication_url": "https://clinicaltrials.gov/study/NCT05527340",
"title": "Multicenter, Phase II, National and Open-label Study to Evaluate Iberdomide-dexamethasone Alone or in Combination With Standard MM Treatment Regimens in Transplant Ineligible Newly Diagnosed Patients.",
"has_exemption": false,
"start_date": "2022-12-15",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "PETHEMA Foundation",
"sponsor_slug": "pethema-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05382338",
"publication_url": "https://clinicaltrials.gov/study/NCT05382338",
"title": "A Phase 3 Study of Sodium Thiosulfate for Reduction of Cisplatin-Induced Ototoxicity in Children With Average-Risk Medulloblastoma and Reduced Therapy in Children With Medulloblastoma With Low-Risk Features",
"has_exemption": false,
"start_date": "2023-02-20",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05776069",
"publication_url": "https://clinicaltrials.gov/study/NCT05776069",
"title": "A Multi-Modular Trial to Evaluate VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease and Other Bleeding Disorders (VIVID)",
"has_exemption": false,
"start_date": "2023-03-16",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vega Therapeutics, Inc",
"sponsor_slug": "vega-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05526144",
"publication_url": "https://clinicaltrials.gov/study/NCT05526144",
"title": "Low Dose Thyroid Hormone, Mitochondrial Fatty Acid Oxidation, and Treatment of Nonalcoholic Steatohepatitis (NASH)",
"has_exemption": false,
"start_date": "2023-04-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05700721",
"publication_url": "https://clinicaltrials.gov/study/NCT05700721",
"title": "Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)",
"has_exemption": false,
"start_date": "2023-06-02",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05898620",
"publication_url": "https://clinicaltrials.gov/study/NCT05898620",
"title": "A Baseline-Controlled, Open-Label, Multicenter, Single-Arm, Pivotal Study to Evaluate the Efficacy, Safety, and Tolerability of NGN-401 in Subjects With Rett Syndrome (Embolden)",
"has_exemption": false,
"start_date": "2023-06-13",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurogene Inc.",
"sponsor_slug": "neurogene-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05616546",
"publication_url": "https://clinicaltrials.gov/study/NCT05616546",
"title": "Longitudinal Analysis of Bone Marrow and Peripheral Blood Immune Responses to Influenza Vaccination in a Healthy Adult Cohort",
"has_exemption": false,
"start_date": "2023-10-16",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06126380",
"publication_url": "https://clinicaltrials.gov/study/NCT06126380",
"title": "AT-1501-K209: BESTOW-EXTENSION: A Phase 2, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients",
"has_exemption": false,
"start_date": "2023-10-25",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eledon Pharmaceuticals",
"sponsor_slug": "eledon-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05977751",
"publication_url": "https://clinicaltrials.gov/study/NCT05977751",
"title": "FINALE: Prospective Multi-Center Trial for FemBloc INtratubal Occlusion for TranscervicAL PErmanent Birth Control",
"has_exemption": false,
"start_date": "2023-10-31",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Femasys Inc.",
"sponsor_slug": "femasys-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06105749",
"publication_url": "https://clinicaltrials.gov/study/NCT06105749",
"title": "Outcome of Biennial Screening Contrast-Enhanced Mammography (CEM) in Women With a Personal History of Breast Cancer (PHBC)",
"has_exemption": false,
"start_date": "2023-11-08",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wendie Berg",
"sponsor_slug": "wendie-berg",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06084234",
"publication_url": "https://clinicaltrials.gov/study/NCT06084234",
"title": "National Liver Cancer Screening Trial",
"has_exemption": false,
"start_date": "2023-12-26",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07325175",
"publication_url": "https://clinicaltrials.gov/study/NCT07325175",
"title": "Quantifying Motor Network Dynamics to Predict and Enhance Outcomes in Pediatric Dystonia",
"has_exemption": false,
"start_date": "2024-01-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Medical Center, Cincinnati",
"sponsor_slug": "childrens-hospital-medical-center-cincinnati",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06238648",
"publication_url": "https://clinicaltrials.gov/study/NCT06238648",
"title": "Multicenter, Randomized Phase II Study of Epcoritamab for Patients With Aggressive B-Cell Lymphomas Achieving a Partial Response After CD19-Directed CAR-T Therapy",
"has_exemption": false,
"start_date": "2024-01-31",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Academic and Community Cancer Research United",
"sponsor_slug": "academic-and-community-cancer-research-united",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06264609",
"publication_url": "https://clinicaltrials.gov/study/NCT06264609",
"title": "Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover - Follow Up Study",
"has_exemption": false,
"start_date": "2024-02-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Paul F Netzel",
"sponsor_slug": "paul-f-netzel",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06164275",
"publication_url": "https://clinicaltrials.gov/study/NCT06164275",
"title": "A Phase II Multi-Center Open-Label Trial of Six Doses of Pembrolizumab Monotherapy Prior to Limited Chemotherapy as Front-Line Therapy for Patients With Classical Hodgkin Lymphoma, Including Elderly Patients.",
"has_exemption": false,
"start_date": "2024-02-06",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06121297",
"publication_url": "https://clinicaltrials.gov/study/NCT06121297",
"title": "A Phase 1/2, Open-label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T Cells (CABA-201) in Subjects With Active Systemic Lupus Erythematosus",
"has_exemption": false,
"start_date": "2024-02-16",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Cabaletta Bio",
"sponsor_slug": "cabaletta-bio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06227949",
"publication_url": "https://clinicaltrials.gov/study/NCT06227949",
"title": "FSH and LH Versus FSH Alone for Ovarian Stimulation in Non-hormone Sensitive Onco-fertility Patients: an Exploratory Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2024-02-29",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ellen Greenblatt",
"sponsor_slug": "ellen-greenblatt",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06292208",
"publication_url": "https://clinicaltrials.gov/study/NCT06292208",
"title": "Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetic (PK) and Preliminary Efficacy of IBD0333 in Patients With Locally Advanced/Metastatic Solid Tumor or Non-Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2024-03-09",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SUNHO（China）BioPharmaceutical CO., Ltd.",
"sponsor_slug": "sunhochinabiopharmaceutical-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06216470",
"publication_url": "https://clinicaltrials.gov/study/NCT06216470",
"title": "Phase II Investigator-Initiated Study to Understand the Vaccinal Effect of HBsAg Monoclonal Ab VIR-3434 in Chronic Hepatitis B Infection",
"has_exemption": false,
"start_date": "2024-03-13",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University Health Network, Toronto",
"sponsor_slug": "university-health-network-toronto",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06172296",
"publication_url": "https://clinicaltrials.gov/study/NCT06172296",
"title": "A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma",
"has_exemption": false,
"start_date": "2024-04-19",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06964152",
"publication_url": "https://clinicaltrials.gov/study/NCT06964152",
"title": "Prospective Use of Computational Cardiac Imaging Analysis to Guide Ventricular Tachycardia Ablation Procedures (AI-VT)",
"has_exemption": false,
"start_date": "2024-05-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06200103",
"publication_url": "https://clinicaltrials.gov/study/NCT06200103",
"title": "Minority-Inclusive Imaging Biomarker-Based End of Therapy Trial for 177Lu-PSMA-617, a Randomized De-Escalation Theranostic Trial for Metastatic Castrate Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2024-05-03",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06395402",
"publication_url": "https://clinicaltrials.gov/study/NCT06395402",
"title": "177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry",
"has_exemption": false,
"start_date": "2024-05-03",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Iowa",
"sponsor_slug": "university-of-iowa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06215469",
"publication_url": "https://clinicaltrials.gov/study/NCT06215469",
"title": "Amma™ Portable Scalp Cooling System (PSCS) Study: A Post-market Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss in Women Receiving Specific Chemotherapy Regimens for Early-stage Breast Cancer",
"has_exemption": false,
"start_date": "2024-05-16",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06207799",
"publication_url": "https://clinicaltrials.gov/study/NCT06207799",
"title": "Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma",
"has_exemption": false,
"start_date": "2024-07-17",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06526338",
"publication_url": "https://clinicaltrials.gov/study/NCT06526338",
"title": "A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of IP-001 as Adjuvant Therapy in Participants With Hepatocellular Carcinoma After Complete Radiological Response After Surgical Resection and Local Ablation or Local Ablation Alone",
"has_exemption": false,
"start_date": "2024-07-24",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Robert C. Martin",
"sponsor_slug": "robert-c-martin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06107764",
"publication_url": "https://clinicaltrials.gov/study/NCT06107764",
"title": "Cerebellar Modulation of Cognition in Psychosis",
"has_exemption": false,
"start_date": "2024-07-31",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mclean Hospital",
"sponsor_slug": "mclean-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06445946",
"publication_url": "https://clinicaltrials.gov/study/NCT06445946",
"title": "DECIDE: A Comparative Effectiveness Trial of Oral Metformin Versus Injectable Insulin for the Treatment of Gestational Diabetes",
"has_exemption": false,
"start_date": "2024-08-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ohio State University",
"sponsor_slug": "ohio-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06061809",
"publication_url": "https://clinicaltrials.gov/study/NCT06061809",
"title": "Open-Label, Single-Arm Phase 2 Study of Nogapendekin Alfa Inbakicept, PD-L1 t-haNK, Bevacizumab and Randomized Phase 2B Study of Nogapendekin Alfa Inbakicept, Bevacizumab, and Tumor Treatment Fields With or Without PD-L1 t-haNK in Participants With Recurrent or Progressive Glioblastoma",
"has_exemption": false,
"start_date": "2024-08-07",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ImmunityBio, Inc.",
"sponsor_slug": "immunitybio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06518551",
"publication_url": "https://clinicaltrials.gov/study/NCT06518551",
"title": "A Phase I/II Study of Elotuzumab and Iberdomide and Dexamethasone Post Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2024-11-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Omar Nadeem, MD",
"sponsor_slug": "omar-nadeem-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06500975",
"publication_url": "https://clinicaltrials.gov/study/NCT06500975",
"title": "Long Term Outcomes After Vestibular Implantation",
"has_exemption": false,
"start_date": "2024-12-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06735976",
"publication_url": "https://clinicaltrials.gov/study/NCT06735976",
"title": "Efficacy & Safety of LOBO™ Vascular Occlusion Device for Embolization of Pulmonary Arteriovenous Malformations (PAVM)",
"has_exemption": false,
"start_date": "2024-12-17",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of North Carolina, Chapel Hill",
"sponsor_slug": "university-of-north-carolina-chapel-hill",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06711705",
"publication_url": "https://clinicaltrials.gov/study/NCT06711705",
"title": "Phase II MRD-Adapted Study of Elranatamab in Relapsed/Refractory",
"has_exemption": false,
"start_date": "2024-12-18",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06769633",
"publication_url": "https://clinicaltrials.gov/study/NCT06769633",
"title": "A Phase 2 Open-label (Core Phase Plus Extension Phase) With 2 Cohorts Study to Assess the Pharmacokinetics and Safety of Givinostat in DMD Patients Ages From at Least 2 Years to Less Than 6 Years Old",
"has_exemption": false,
"start_date": "2025-01-02",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Italfarmaco",
"sponsor_slug": "italfarmaco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06132178",
"publication_url": "https://clinicaltrials.gov/study/NCT06132178",
"title": "Assessing the Safety, Tolerability, and Efficacy of Psilocybin Therapy Followed by Accelerated Intermittent Theta Burst (aiTBS) Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment-Resistant Major Depressive Disorder",
"has_exemption": false,
"start_date": "2025-01-10",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas at Austin",
"sponsor_slug": "university-of-texas-at-austin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06797635",
"publication_url": "https://clinicaltrials.gov/study/NCT06797635",
"title": "An Open-label Randomized Phase 2 Study to Evaluate Safety and Efficacy of Patritumab Deruxtecan Plus Pembrolizumab Administered Either Before or After Carboplatin/Paclitaxel Plus Pembrolizumab Compared With Pembrolizumab in Combination With Chemotherapy Followed by Surgery and Adjuvant Pembrolizumab for High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer (HERTHENA-Breast03)",
"has_exemption": false,
"start_date": "2025-03-20",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07064018",
"publication_url": "https://clinicaltrials.gov/study/NCT07064018",
"title": "Phase Ib/IIa Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies",
"has_exemption": false,
"start_date": "2025-04-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Irvine",
"sponsor_slug": "university-of-california-irvine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07003425",
"publication_url": "https://clinicaltrials.gov/study/NCT07003425",
"title": "A Long-term Extension Study to Evaluate the Safety and Efficacy of APG777 in Patients With Atopic Dermatitis Previously Treated With APG777",
"has_exemption": false,
"start_date": "2025-05-14",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Apogee Therapeutics, Inc.",
"sponsor_slug": "apogee-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06736171",
"publication_url": "https://clinicaltrials.gov/study/NCT06736171",
"title": "Prescription of Robotic Exoskeletons for Ambulation Recovery Post Stroke",
"has_exemption": false,
"start_date": "2025-05-15",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kessler Foundation",
"sponsor_slug": "kessler-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06976801",
"publication_url": "https://clinicaltrials.gov/study/NCT06976801",
"title": "Prospective, Randomized-control Trial Comparing Standard Intramedullary Tibial Fixation With Micromotion Tibial Intramedullary Fixation",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06765109",
"publication_url": "https://clinicaltrials.gov/study/NCT06765109",
"title": "A Phase 3 Study of the Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor NVL-655 Compared to Alectinib in First-Line Treatment of Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer (ALKAZAR)",
"has_exemption": false,
"start_date": "2025-07-17",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nuvalent Inc.",
"sponsor_slug": "nuvalent-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06508931",
"publication_url": "https://clinicaltrials.gov/study/NCT06508931",
"title": "A Single-arm, Multi-center, Open-label Phase II Study to Determine the Safety and Efficacy of MB-CART2019.1 in Pediatric Subjects With Relapsed/Refractory Mature B-cell Neoplasms Who Have Relapsed After One or More Prior Therapies, Including Subjects With Primary Refractory Disease",
"has_exemption": false,
"start_date": "2025-08-04",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Miltenyi Biomedicine GmbH",
"sponsor_slug": "miltenyi-biomedicine-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06740968",
"publication_url": "https://clinicaltrials.gov/study/NCT06740968",
"title": "Improving Neural Oscillation and Synchrony Between Motor and Auditory Regions in Stuttering Using Personalized Transcranial Alternating Current Stimulation (tACS)",
"has_exemption": false,
"start_date": "2025-08-05",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07144813",
"publication_url": "https://clinicaltrials.gov/study/NCT07144813",
"title": "Clinical Post- Approval Study of the Neuspera Sacral Neuromodulation (SNM) System in Patients With Symptoms of Urinary Urgency Incontinence (UUI)",
"has_exemption": false,
"start_date": "2025-09-03",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Neuspera Medical, Inc.",
"sponsor_slug": "neuspera-medical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06561074",
"publication_url": "https://clinicaltrials.gov/study/NCT06561074",
"title": "A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy)",
"has_exemption": false,
"start_date": "2025-09-25",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07449039",
"publication_url": "https://clinicaltrials.gov/study/NCT07449039",
"title": "Postpartum Continuous Glucose Monitoring for Type 2 Diabetes Mellitus Risk Evaluation in Patients With Gestational Diabetes Mellitus: POSTPOD Trial",
"has_exemption": false,
"start_date": "2025-09-28",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07010146",
"publication_url": "https://clinicaltrials.gov/study/NCT07010146",
"title": "Role of Estrogen Formulation and Route of Delivery on Skeletal Outcomes in Functional Hypothalmic Amenorrhea",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Virginia",
"sponsor_slug": "university-of-virginia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07173751",
"publication_url": "https://clinicaltrials.gov/study/NCT07173751",
"title": "A Phase III, Multisite, Randomized, Double-Blind Trial of BNT327 in Combination With Chemotherapy Versus Placebo With Chemotherapy in Patients With Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC Determined Ineligible for PD(L)1 Therapy Based on PD-L1 Negative Disease",
"has_exemption": false,
"start_date": "2025-10-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Biontech SE",
"sponsor_slug": "biontech-se",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07188532",
"publication_url": "https://clinicaltrials.gov/study/NCT07188532",
"title": "Biologically-Adapted, Dose-Escalated Accelerated Radiotherapy for Ewing Sarcoma (BEAR)",
"has_exemption": false,
"start_date": "2025-11-24",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07454356",
"publication_url": "https://clinicaltrials.gov/study/NCT07454356",
"title": "Comparing High Intensity Stretch Device Combined With Physical Therapy Versus Physical Therapy Alone to Prevent Motion-Restoring Surgery Following Primary Total Knee Arthroplasty: Study Protocol for a Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-12-09",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ermi LLC",
"sponsor_slug": "ermi-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07283367",
"publication_url": "https://clinicaltrials.gov/study/NCT07283367",
"title": "A Phase Ib/II Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of HS-20110 Combination Therapies in Patients With Advanced Colorectal Cancer.",
"has_exemption": false,
"start_date": "2025-12-22",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hansoh BioMedical R&D Company",
"sponsor_slug": "hansoh-biomedical-rd-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07188558",
"publication_url": "https://clinicaltrials.gov/study/NCT07188558",
"title": "A Phase 3 Randomized Controlled Trial of Rondecabtagene Autoleucel , an Autologous, Dual-targeting CD19/CD20 CAR T-Cell Product Candidate, Vs. Investigator's Choice of CD19 CAR T-Cell Therapy in Patients With Relapsed or Refractory Large B-Cell Lymphoma in the Second-line Setting",
"has_exemption": false,
"start_date": "2026-01-12",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Lyell Immunopharma, Inc.",
"sponsor_slug": "lyell-immunopharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07258771",
"publication_url": "https://clinicaltrials.gov/study/NCT07258771",
"title": "Acute Severe Ulcerative Colitis- Upadacitinib Combined With Corticosteroids vs Corticosteroid Monotherapy Induction While Transitioning Away From the Emergency Setting (ACUTE): A Phase IV, Single Center, Partially Blinded, Randomized Study",
"has_exemption": false,
"start_date": "2026-01-16",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Berinstein, Jeffrey",
"sponsor_slug": "berinstein-jeffrey",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07060638",
"publication_url": "https://clinicaltrials.gov/study/NCT07060638",
"title": "Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial",
"has_exemption": false,
"start_date": "2026-01-27",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Samer Gawrieh",
"sponsor_slug": "samer-gawrieh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07380256",
"publication_url": "https://clinicaltrials.gov/study/NCT07380256",
"title": "Effects of Impaired Visual Acuity and Binocular Control Abnormalities (VABC) on Vestibulo-ocular Reflex (VOR) Adaptation in Adults With and Without Vestibular Hypofunction",
"has_exemption": false,
"start_date": "2026-02-04",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06681220",
"publication_url": "https://clinicaltrials.gov/study/NCT06681220",
"title": "Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC",
"has_exemption": false,
"start_date": "2026-02-23",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07497178",
"publication_url": "https://clinicaltrials.gov/study/NCT07497178",
"title": "A Prospective Cohort Study of High Intensity Focused Ultrasound Ablation for Brain Lesions in Children With Drug Resistant Epilepsy",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The Hospital for Sick Children",
"sponsor_slug": "the-hospital-for-sick-children",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07560631",
"publication_url": "https://clinicaltrials.gov/study/NCT07560631",
"title": "SeeMe: A Multimodal Behavioral-Electrophysiological Tool for Real-Time Detection of Motor Behavior in Brain Injury Patients",
"has_exemption": false,
"start_date": "2026-03-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stony Brook University",
"sponsor_slug": "stony-brook-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07214376",
"publication_url": "https://clinicaltrials.gov/study/NCT07214376",
"title": "A Randomized Placebo-procedure Controlled Trial of the Multi-Pole Pulmonary Artery Radiofrequency Ablation Enhancor System PULmonary Artery Denervation Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Pulnovo Medical, Inc.",
"sponsor_slug": "pulnovo-medical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07112196",
"publication_url": "https://clinicaltrials.gov/study/NCT07112196",
"title": "Adaptive, Phase 2/3, Randomized, Double-Blind Trial Investigating the Efficacy and Safety of Visugromab Versus Placebo in Patients With Cancer-associated Cachexia",
"has_exemption": false,
"start_date": "2026-04-16",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "CatalYm GmbH",
"sponsor_slug": "catalym-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07439094",
"publication_url": "https://clinicaltrials.gov/study/NCT07439094",
"title": "A First-in-Human, Multicenter, Open-Label, Phase 1/2a Study to Evaluate the Safety, Efficacy and Pharmacokinetics of CKD-703 in Advanced c-Met Expressing Solid Tumors, and in MET Amplified and c-Met Overexpressing Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-04-16",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Chong Kun Dang Pharmaceutical",
"sponsor_slug": "chong-kun-dang-pharmaceutical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07162480",
"publication_url": "https://clinicaltrials.gov/study/NCT07162480",
"title": "Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Carcinoma Subtype I (ACC-I)",
"has_exemption": false,
"start_date": "2026-04-29",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07300982",
"publication_url": "https://clinicaltrials.gov/study/NCT07300982",
"title": "Studies of Insulin and Glucagon Action in the Liver",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07112105",
"publication_url": "https://clinicaltrials.gov/study/NCT07112105",
"title": "Repetitive Transcranial Magnetic Stimulation Treatment of Stimulant Use Disorder",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07454980",
"publication_url": "https://clinicaltrials.gov/study/NCT07454980",
"title": "Pivotal TRIal to Evaluate TraNsvenous TrIcuspid Valve ReplacemenT With Lux Valve Plus System in Patients With Severe or Greater Tricuspid Regurgitation - Clinical SafetY and Effectiveness",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jenscare Innovation Inc.",
"sponsor_slug": "jenscare-innovation-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07394036",
"publication_url": "https://clinicaltrials.gov/study/NCT07394036",
"title": "The Effect of Ipratropium Bromide on Exercise-Induced Laryngeal Obstruction (EILO) in Pediatric Patients",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Cook Children's Health Care System",
"sponsor_slug": "cook-childrens-health-care-system",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07556718",
"publication_url": "https://clinicaltrials.gov/study/NCT07556718",
"title": "Amitriptyline for IBS-like Symptoms in Quiescent Crohn's Disease: A Multicenter Randomized Placebo-Controlled Trial",
"has_exemption": false,
"start_date": "2026-06-03",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07511049",
"publication_url": "https://clinicaltrials.gov/study/NCT07511049",
"title": "Safety and Tolerability of Intravenous Brincidofovir as an Antiviral for Treatment of Progressive Multifocal Leukoencephalopathy: A Pilot Study",
"has_exemption": false,
"start_date": "2026-06-05",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Neurological Disorders and Stroke (NINDS)",
"sponsor_slug": "national-institute-of-neurological-disorders-and-stroke-ninds",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05494697",
"publication_url": "https://clinicaltrials.gov/study/NCT05494697",
"title": "A Phase 2 Randomized Open-Label Controlled Study to Evaluate the Efficacy and Safety of Ampligen in Combination With Standard of Care Versus SOC Alone Following First-Line Therapy in Subjects With Locally Advanced Pancreatic Adenocarcinoma",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AIM ImmunoTech Inc.",
"sponsor_slug": "aim-immunotech-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07220915",
"publication_url": "https://clinicaltrials.gov/study/NCT07220915",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Panzyga for Prevention of Major Infection in Patients With Hypogammaglobulinemia and Autoimmune or Rheumatic Conditions Receiving Treatment With B-cell Depletion Therapy (\"PROTECT\")",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Octapharma",
"sponsor_slug": "octapharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07285148",
"publication_url": "https://clinicaltrials.gov/study/NCT07285148",
"title": "An Open-label, Multicenter Phase Ib/II Study to Evaluate the Safety, Efficacy and Pharmacokinetic Characteristics of ANS014004 in Combination With EGFR-TKI in Patients With EGFR Mutation-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Beijing Pearl Biotechnology Limited Liability Company",
"sponsor_slug": "beijing-pearl-biotechnology-limited-liability-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07579195",
"publication_url": "https://clinicaltrials.gov/study/NCT07579195",
"title": "Consolidative Radiation Therapy or Cystectomy After Initial Favorable Response Succeeding Enfortumab Vedotin Plus Pembrolizumab (REINFORCE)--- A Phase I/II Pilot Feasibility Trial",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07564141",
"publication_url": "https://clinicaltrials.gov/study/NCT07564141",
"title": "A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Platinum-Based Chemotherapy ± Bevacizumab as 2L Treatment in Participants With Recurrent Platinum-Sensitive Ovarian Cancer",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Genmab",
"sponsor_slug": "genmab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06820138",
"publication_url": "https://clinicaltrials.gov/study/NCT06820138",
"title": "Low Intensity Focused Ultrasound for Posttraumatic Stress Disorder",
"has_exemption": false,
"start_date": "2026-08-03",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07594145",
"publication_url": "https://clinicaltrials.gov/study/NCT07594145",
"title": "Accelerating Breakthrough Targeted New Therapies for Cardio-Renal Complications in People With T1D (Precision T1D Platform)",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Oregon Health and Science University",
"sponsor_slug": "oregon-health-and-science-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07600658",
"publication_url": "https://clinicaltrials.gov/study/NCT07600658",
"title": "A Phase I/II, First-In-Human Trial to Evaluate the Safety, Tolerability, and Pharmacokinetic Activity to Prevent or Treat Neuropsychiatric Symptoms in Pediatric Subjects With Timothy Syndrome",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07308938",
"publication_url": "https://clinicaltrials.gov/study/NCT07308938",
"title": "Trial of Topical Fluorometholone as Adjunctive Therapy for Bacterial Corneal Ulcers",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vishal Jhanji",
"sponsor_slug": "vishal-jhanji",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07027969",
"publication_url": "https://clinicaltrials.gov/study/NCT07027969",
"title": "Efficacy of Cardiometabolic Risk Factor Control Through Metabolic Surgery on Management and Severity of Atrial Fibrillation: METSAFE Randomized Clinical Trial",
"has_exemption": false,
"start_date": "2026-11-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ali Aminian",
"sponsor_slug": "ali-aminian",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02864888",
"publication_url": "https://clinicaltrials.gov/study/NCT02864888",
"title": "A Controlled, Study of the Effect of Combination Antineoplaston Therapy [Atengenal (A10) and Astugenal (AS2-1)] on the QT/QTc Interval In Subjects With Newly Diagnosed Diffuse, Intrinsic, Brainstem Glioma",
"has_exemption": false,
"start_date": "2027-06-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Burzynski Research Institute",
"sponsor_slug": "burzynski-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03206060",
"publication_url": "https://clinicaltrials.gov/study/NCT03206060",
"title": "Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma",
"has_exemption": false,
"start_date": "2017-10-10",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04337515",
"publication_url": "https://clinicaltrials.gov/study/NCT04337515",
"title": "A Feasibility Study of Using the CiniMacs® Device for Alpha/Best T-Cell Depletion in Stem Cell Transplant Recipients",
"has_exemption": false,
"start_date": "2019-12-19",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Christopher Dvorak",
"sponsor_slug": "christopher-dvorak",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05088798",
"publication_url": "https://clinicaltrials.gov/study/NCT05088798",
"title": "Use of18F-DOPA PET/MRI for the Detection and Localization of Focal Forms of Hyperinsulinism",
"has_exemption": false,
"start_date": "2020-09-10",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02773082",
"publication_url": "https://clinicaltrials.gov/study/NCT02773082",
"title": "Reclaim™ Deep Brain Stimulation (DBS) Therapy for Obsessive-Compulsive Disorder (OCD)",
"has_exemption": false,
"start_date": "2024-07-06",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwell Health",
"sponsor_slug": "northwell-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06068543",
"publication_url": "https://clinicaltrials.gov/study/NCT06068543",
"title": "A Phase 2 Randomized Controlled Trial of Epigallocatechin-3-Gallate (EGCG) on Frailty and Inflammation in Older Survivors of Cancer",
"has_exemption": false,
"start_date": "2024-10-25",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Rochester",
"sponsor_slug": "university-of-rochester",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07043972",
"publication_url": "https://clinicaltrials.gov/study/NCT07043972",
"title": "Phase II Study of Second-line Gemcitabine Plus Carboplatin After Progression on Enfortumab Vedotin With Pembrolizumab in Advanced or Metastatic Urothelial Carcinoma",
"has_exemption": false,
"start_date": "2025-07-09",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Fox Chase Cancer Center",
"sponsor_slug": "fox-chase-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06440707",
"publication_url": "https://clinicaltrials.gov/study/NCT06440707",
"title": "Transcranial Electrical Stimulation in Stroke EaRly After Onset Clinical Trial 2",
"has_exemption": false,
"start_date": "2025-07-15",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07300865",
"publication_url": "https://clinicaltrials.gov/study/NCT07300865",
"title": "Does the Thickness of the Gastrostomy Affect the Incidence of Complications? A Prospective Randomized Single-Center Study in Children",
"has_exemption": false,
"start_date": "2025-11-20",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Therese Hössjer",
"sponsor_slug": "therese-hossjer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07506239",
"publication_url": "https://clinicaltrials.gov/study/NCT07506239",
"title": "PNOC042: A Phase 2, Multi-institutional Trial, Evaluating the Efficacy of Laser Interstitial Thermal Therapy (LITT) in Children, Adolescents and Young Adults With Recurrent or Progressive Low-grade Gliomas (LGG)",
"has_exemption": false,
"start_date": "2026-03-25",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07220252",
"publication_url": "https://clinicaltrials.gov/study/NCT07220252",
"title": "Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis (RMS)",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "TG Therapeutics, Inc.",
"sponsor_slug": "tg-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06303193",
"publication_url": "https://clinicaltrials.gov/study/NCT06303193",
"title": "Phase I/II Trial of Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms",
"has_exemption": false,
"start_date": "2026-06-23",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06214793",
"publication_url": "https://clinicaltrials.gov/study/NCT06214793",
"title": "A Phase II Study of Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC) of the Breast (TaCe)",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Megan Kruse, MD",
"sponsor_slug": "megan-kruse-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07647614",
"publication_url": "https://clinicaltrials.gov/study/NCT07647614",
"title": "A Phase II, Randomized, Double-blind, Placebo-controlled, Parallel Study to Evaluate the Efficacy and Safety of ENERGI-F705 Tablets in Combination With Standard of Care for Treating Subjects With Parkinson's Disease",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Energenesis Biomedical Co., Ltd.",
"sponsor_slug": "energenesis-biomedical-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07587879",
"publication_url": "https://clinicaltrials.gov/study/NCT07587879",
"title": "A Phase 1/2a Clinical Study to Evaluate the Safety Tolerability, Pharmacokinetics, and Preliminary Efficacy of a Novel mRNA-LNP PMC2129G12-Based Immunotherapy in Patients With Advanced Malignant Solid Tumors",
"has_exemption": false,
"start_date": "2027-01-01",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "IntraAb, Inc.",
"sponsor_slug": "intraab-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07635862",
"publication_url": "https://clinicaltrials.gov/study/NCT07635862",
"title": "A Randomized Controlled Trial of Ganaxolone for Children With Autism Spectrum Disorder",
"has_exemption": false,
"start_date": "2027-01-01",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07154745",
"publication_url": "https://clinicaltrials.gov/study/NCT07154745",
"title": "A Single Arm Study to Evaluate the Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Paroxysmal Nocturnal Hemoglobinuria With Inadequate Control of Intravascular Hemolysis on Currently Available C5 Inhibitor Therapy",
"has_exemption": false,
"start_date": "2026-05-30",
"completion_date": "2030-01-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07213674",
"publication_url": "https://clinicaltrials.gov/study/NCT07213674",
"title": "A Phase 3, Open-label, Multicenter, Randomized Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2025-11-28",
"completion_date": "2030-01-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07335796",
"publication_url": "https://clinicaltrials.gov/study/NCT07335796",
"title": "A Phase 2 Study of Androgen Deprivation Therapy and BMS986365 in High-Risk Localized Prostate Cancer Patients Prior to Radical Prostatectomy",
"has_exemption": false,
"start_date": "2026-01-09",
"completion_date": "2030-01-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07517263",
"publication_url": "https://clinicaltrials.gov/study/NCT07517263",
"title": "A Single Arm, Multicenter, Open-label Extension (OLE) Trial to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230) in Participants Who Completed the Parent Lp(a)HORIZON Trial",
"has_exemption": false,
"start_date": "2026-05-11",
"completion_date": "2030-01-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07459751",
"publication_url": "https://clinicaltrials.gov/study/NCT07459751",
"title": "A Randomized, Open-Label, Multi-center, Global Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) Monotherapy or HLX43 in Combination With HLX07 (Recombinant Anti-EGFR Humanized Monoclonal Antibody Injection) Versus Docetaxel in Previously Treated Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2026-05-27",
"completion_date": "2030-01-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Shanghai Henlius Biotech",
"sponsor_slug": "shanghai-henlius-biotech",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05800015",
"publication_url": "https://clinicaltrials.gov/study/NCT05800015",
"title": "A Randomized, Double-Blind Phase 2/3 Study of Fianlimab (Anti-LAG-3 Antibody), Cemiplimab (Anti-PD-1 Antibody), and Chemotherapy Versus Cemiplimab and Chemotherapy in First-Line Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Irrespective of PD-L1 Expression Levels",
"has_exemption": false,
"start_date": "2023-08-08",
"completion_date": "2030-01-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01687608",
"publication_url": "https://clinicaltrials.gov/study/NCT01687608",
"title": "A Phase 1/2 Open-Label, Single Ascending Dose Trial of a Self-Complementing Optimized Adeno-associated Virus Serotype 8 Factor IX Gene Therapy (AskBio009) in Adults With Hemophilia B",
"has_exemption": false,
"start_date": "2013-02-11",
"completion_date": "2030-01-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Baxalta now part of Shire",
"sponsor_slug": "baxalta-now-part-of-shire",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06868277",
"publication_url": "https://clinicaltrials.gov/study/NCT06868277",
"title": "A Phase III, Randomized, Double-blind, Multicenter, Global Study of Rilvegostomig or Pembrolizumab Monotherapy for the First-line Treatment of Patients With PD-L1-high Metastatic Non-small Cell Lung Cancer (ARTEMIDE-Lung04)",
"has_exemption": false,
"start_date": "2025-04-10",
"completion_date": "2030-01-17",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06572605",
"publication_url": "https://clinicaltrials.gov/study/NCT06572605",
"title": "A Phase 1b/2 Study of Talquetamab Plus Concomitant Priming Radiotherapy in Multiple Myeloma With Extramedullary Disease",
"has_exemption": false,
"start_date": "2025-08-29",
"completion_date": "2030-01-18",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07519772",
"publication_url": "https://clinicaltrials.gov/study/NCT07519772",
"title": "A Phase 1b/2 Study to Evaluate the Safety and Efficacy of MK-1045 Monotherapy or in Combination With Other Anticancer Agents in Participants With Non-Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2026-05-03",
"completion_date": "2030-01-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07410117",
"publication_url": "https://clinicaltrials.gov/study/NCT07410117",
"title": "A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess Efficacy and Safety of REGN7508, a Monoclonal Antibody Against FXI, for Primary Prophylaxis of Cancer-Associated Thrombosis for Participants With Solid Tumors Undergoing Cancer Treatment (ROXI-CAT-I)",
"has_exemption": false,
"start_date": "2026-03-09",
"completion_date": "2030-01-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04638647",
"publication_url": "https://clinicaltrials.gov/study/NCT04638647",
"title": "An Open-label, Multi-center Protocol for Patients Who Have Completed a Previous Novartis Sponsored Secukinumab Study and Are Judged by the Investigator to Benefit From Continued Secukinumab Treatment",
"has_exemption": false,
"start_date": "2020-12-22",
"completion_date": "2030-01-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04008368",
"publication_url": "https://clinicaltrials.gov/study/NCT04008368",
"title": "Repeat Peripheral Blood Stem Cell Transplantation for Patients With Sickle Cell Disease or Beta-Thalassemia and Falling Donor Myeloid Chimerism Levels",
"has_exemption": false,
"start_date": "2019-10-24",
"completion_date": "2030-01-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Heart, Lung, and Blood Institute (NHLBI)",
"sponsor_slug": "national-heart-lung-and-blood-institute-nhlbi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05464719",
"publication_url": "https://clinicaltrials.gov/study/NCT05464719",
"title": "A Phase II Study of Loncastuximab Tesirine as Consolidation Strategy in Patients With LBCL in PR After CAR T-cell Therapy",
"has_exemption": false,
"start_date": "2022-09-23",
"completion_date": "2030-01-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06205485",
"publication_url": "https://clinicaltrials.gov/study/NCT06205485",
"title": "A Phase 3 Randomized Trial Of Neoadjuvant Chemotherapy, Excision And Observation Versus Chemoradiotherapy For Early Rectal Cancer",
"has_exemption": false,
"start_date": "2024-06-26",
"completion_date": "2030-01-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Canadian Cancer Trials Group",
"sponsor_slug": "canadian-cancer-trials-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07399977",
"publication_url": "https://clinicaltrials.gov/study/NCT07399977",
"title": "A Nonrandomized Trial Using DNA Liquid Biopsies to Guide Anticoagulation For Patients With Cancer-Associated Thromboembolism",
"has_exemption": false,
"start_date": "2026-01-30",
"completion_date": "2030-01-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00785525",
"publication_url": "https://clinicaltrials.gov/study/NCT00785525",
"title": "Filgrastim-Mobilized Peripheral Blood Stem Cells for Allogeneic Transplantation With Unrelated Donors",
"has_exemption": false,
"start_date": "1997-02-28",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Center for International Blood and Marrow Transplant Research",
"sponsor_slug": "center-for-international-blood-and-marrow-transplant-research",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02605785",
"publication_url": "https://clinicaltrials.gov/study/NCT02605785",
"title": "A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy",
"has_exemption": false,
"start_date": "2015-11-30",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03599752",
"publication_url": "https://clinicaltrials.gov/study/NCT03599752",
"title": "The Role of Multimodality Management in Risk-Stratified Patients With Lung-Limited Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2018-07-02",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03801083",
"publication_url": "https://clinicaltrials.gov/study/NCT03801083",
"title": "A Phase 2 Study to Evaluate the Efficacy and Safety of Adoptive Transfer of Autologous Tumor Infiltrating Lymphocytes in Patients With Locally Advanced, Recurrent, or Metastatic Biliary Tract Cancers",
"has_exemption": false,
"start_date": "2019-02-19",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Udai Kammula",
"sponsor_slug": "udai-kammula",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04375722",
"publication_url": "https://clinicaltrials.gov/study/NCT04375722",
"title": "Exogenous Tuning of Neural Oscillations as a Mode of Treatment in Post-stroke Aphasia",
"has_exemption": false,
"start_date": "2020-01-04",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05030441",
"publication_url": "https://clinicaltrials.gov/study/NCT05030441",
"title": "A Pilot Study of Ivosidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH1",
"has_exemption": false,
"start_date": "2022-04-01",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05554302",
"publication_url": "https://clinicaltrials.gov/study/NCT05554302",
"title": "Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis",
"has_exemption": false,
"start_date": "2023-01-10",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Baptist Health South Florida",
"sponsor_slug": "baptist-health-south-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05643742",
"publication_url": "https://clinicaltrials.gov/study/NCT05643742",
"title": "A Phase 1/2, Open-Label, Multicenter, Dose Escalation and Cohort Expansion Study of the Safety and Efficacy of Anti-CD19 Allogeneic CRISPR-Cas9-Engineered T Cells (CTX112) in Subjects With Relapsed or Refractory B Cell Malignancies",
"has_exemption": false,
"start_date": "2023-03-10",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "CRISPR Therapeutics AG",
"sponsor_slug": "crispr-therapeutics-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06193551",
"publication_url": "https://clinicaltrials.gov/study/NCT06193551",
"title": "Ovitex in Paraesophageal and Large Hiatal Hernia Repair. (OviPHeR)",
"has_exemption": false,
"start_date": "2024-02-19",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Foregut Research Foundation",
"sponsor_slug": "foregut-research-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06412666",
"publication_url": "https://clinicaltrials.gov/study/NCT06412666",
"title": "A Phase 2/3 Multicenter, Randomized, Double-Blind, Placebo-Controlled and Open-Label Extension Trial to Evaluate the Efficacy and Safety of Aficamten in a Pediatric Population With Symptomatic Obstructive Hypertrophic Cardiomyopathy",
"has_exemption": false,
"start_date": "2024-05-29",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Cytokinetics",
"sponsor_slug": "cytokinetics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06548542",
"publication_url": "https://clinicaltrials.gov/study/NCT06548542",
"title": "A Phase 2a Multicenter, Randomized, Platform Study of Targeted Therapies for the Treatment of Adult Subjects With Moderate to Severe Crohn's Disease",
"has_exemption": false,
"start_date": "2024-09-04",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06559176",
"publication_url": "https://clinicaltrials.gov/study/NCT06559176",
"title": "A Phase 1/2 Study Evaluating Gene Therapy by Transplantation of Autologous CD34+ Stem Cells Modified Ex Vivo Using Prime Editing (PM359) in Participants With Autosomal Recessive Chronic Granulomatous Disease Due to Mutations in the NCF1 Gene",
"has_exemption": false,
"start_date": "2024-10-17",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Prime Medicine, Inc.",
"sponsor_slug": "prime-medicine-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06857773",
"publication_url": "https://clinicaltrials.gov/study/NCT06857773",
"title": "Hepatic Arterial Infusion PUMP Chemotherapy Combined With Systemic Therapy Versus Systemic Therapy Alone as Induction Therapy for Initially Unresectable Colorectal Liver Metastases: a Randomised Controlled Trial",
"has_exemption": false,
"start_date": "2024-11-21",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The Netherlands Cancer Institute",
"sponsor_slug": "the-netherlands-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06581406",
"publication_url": "https://clinicaltrials.gov/study/NCT06581406",
"title": "A Randomized, Phase 2/3, Open-Label Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab Versus Ipilimumab in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma",
"has_exemption": false,
"start_date": "2024-12-17",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Replimune Inc.",
"sponsor_slug": "replimune-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06607406",
"publication_url": "https://clinicaltrials.gov/study/NCT06607406",
"title": "A Randomized Trial of Accelerated Postoperative Radiotherapy for Intermediate- and High-risk Patients With HNSCC (Head and Neck Squamous Cell Carcinoma) Initiating Radiotherapy Greater Than 6 Weeks After Surgery (PORTRush)",
"has_exemption": false,
"start_date": "2025-01-21",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06842355",
"publication_url": "https://clinicaltrials.gov/study/NCT06842355",
"title": "A Multicenter, Phase 2, Dose-Escalation/Dose-Expansion Study of TYRA-300 in Children With Achondroplasia With Open Growth Plates: BEACH301",
"has_exemption": false,
"start_date": "2025-03-04",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Tyra Biosciences, Inc",
"sponsor_slug": "tyra-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06745882",
"publication_url": "https://clinicaltrials.gov/study/NCT06745882",
"title": "Prospective Trial to Assess Real-world Outcomes and Predictive Biomarkers of Response to Pembrolizumab With or Without Chemotherapy in Black Patients With NSCLC",
"has_exemption": false,
"start_date": "2025-06-13",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07076225",
"publication_url": "https://clinicaltrials.gov/study/NCT07076225",
"title": "A Ultrashort Regimen for Drug-susceptible Pulmonary Tuberculosis in Elderly Patients: A Multicenter Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-07-25",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Shenzhen Third People's Hospital",
"sponsor_slug": "shenzhen-third-peoples-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07096193",
"publication_url": "https://clinicaltrials.gov/study/NCT07096193",
"title": "Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07213661",
"publication_url": "https://clinicaltrials.gov/study/NCT07213661",
"title": "Long-term Comparative Effectiveness of 2 Treatments to Arrest Dental Caries in Older Adults",
"has_exemption": false,
"start_date": "2025-10-08",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Case Western Reserve University",
"sponsor_slug": "case-western-reserve-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07157254",
"publication_url": "https://clinicaltrials.gov/study/NCT07157254",
"title": "A Phase 2, Open-label, Basket Study Investigating the Safety and Efficacy of GTX-102 in Adult and Pediatric Subjects With Deletion- or Nondeletion-type Angelman Syndrome",
"has_exemption": false,
"start_date": "2025-10-13",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ultragenyx Pharmaceutical Inc",
"sponsor_slug": "ultragenyx-pharmaceutical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06200259",
"publication_url": "https://clinicaltrials.gov/study/NCT06200259",
"title": "Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement",
"has_exemption": false,
"start_date": "2025-12-15",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Covenant Health Cancer Center",
"sponsor_slug": "covenant-health-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07223307",
"publication_url": "https://clinicaltrials.gov/study/NCT07223307",
"title": "Phase II Trial of REal Time MRI GUided Adaptive Stereotactic Ablative Radiotherapy for Liver Cancers Using a Single Session, Simulation Free Workflow",
"has_exemption": false,
"start_date": "2026-01-23",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07129473",
"publication_url": "https://clinicaltrials.gov/study/NCT07129473",
"title": "Hyperemesis Gravidarum Risk Reduction With Metformin",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Southern California",
"sponsor_slug": "university-of-southern-california",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07303946",
"publication_url": "https://clinicaltrials.gov/study/NCT07303946",
"title": "Double-Blind, Crossover, Feasibility Study of Deep Brain Stimulation of the Anterior Cingulate Bundle (ACB) and the Ventral Anterior Limb of the Internal Capsule (vALIC) in Patients With Intractable Obsessive Compulsive Disorder (OCD)",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rhode Island Hospital",
"sponsor_slug": "rhode-island-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07369115",
"publication_url": "https://clinicaltrials.gov/study/NCT07369115",
"title": "Intra-Cellular Therapies, Inc. / \"A Randomized, Double-blind, Placebo-controlled, Single Site Study to Evaluate the Efficacy of Lumateperone for the Treatment of Major Depressive Disorder (MDD) and Early Life Trauma in Adult Patients Aged 21 to 70 Years",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas at Austin",
"sponsor_slug": "university-of-texas-at-austin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07280468",
"publication_url": "https://clinicaltrials.gov/study/NCT07280468",
"title": "Endotype DIrected Treatment for OSA in Down Syndrome",
"has_exemption": false,
"start_date": "2026-03-14",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Arizona",
"sponsor_slug": "university-of-arizona",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07497399",
"publication_url": "https://clinicaltrials.gov/study/NCT07497399",
"title": "Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis (TAG-MS): A Phase 2, Randomized, Double-Blind, Parallel-Arm Study",
"has_exemption": false,
"start_date": "2026-04-28",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07592000",
"publication_url": "https://clinicaltrials.gov/study/NCT07592000",
"title": "Multicenter, Phase 1/2 Pilot Study of Safety and Efficacy Assessment of Tegoprubart and Calcineurin Inhibitors- Free Immunosuppression Therapy for Pancreatic Islet Transplantation in Patients With T1DM and Chronic Kidney Disease",
"has_exemption": false,
"start_date": "2026-04-29",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07332442",
"publication_url": "https://clinicaltrials.gov/study/NCT07332442",
"title": "Continuous Positive Airway Pressure, Arousability and Links to Mechanisms in Obstructive Sleep Apnea",
"has_exemption": false,
"start_date": "2026-05-18",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07010302",
"publication_url": "https://clinicaltrials.gov/study/NCT07010302",
"title": "A Comparative Clinical Effectiveness Trial of Rituximab Versus Ravulizumab, Inebilizumab, Satralizumab and Eculizumab To Prevent Relapses in Neuromyelitis Optica Spectrum Disorder",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07546812",
"publication_url": "https://clinicaltrials.gov/study/NCT07546812",
"title": "A Phase 2, Open-Label, Multicenter, Randomized Study to Evaluate Denikitug as Monotherapy or in Combination With Nivolumab or Chemotherapy in Participants With HER2-Negative, Unresectable, Recurrent, and/or Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07328503",
"publication_url": "https://clinicaltrials.gov/study/NCT07328503",
"title": "A Phase II Study to Examine the Impact of CD22 CAR T-cells to Extend the Duration of Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia",
"has_exemption": false,
"start_date": "2026-06-23",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07419425",
"publication_url": "https://clinicaltrials.gov/study/NCT07419425",
"title": "Comparing Three Multicomponent Interventions to Help Adults Quit Smoking",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07625644",
"publication_url": "https://clinicaltrials.gov/study/NCT07625644",
"title": "A Phase 3 Open-Label, Randomized Controlled Trial of BL-M14D1 and Atezolizumab vs. Standard-of-Care Therapy in Patients With First-Line Extensive-Stage Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SystImmune Inc.",
"sponsor_slug": "systimmune-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07288151",
"publication_url": "https://clinicaltrials.gov/study/NCT07288151",
"title": "MDMA-Assisted Massed Exposure Therapy for PTSD",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07264920",
"publication_url": "https://clinicaltrials.gov/study/NCT07264920",
"title": "Pediatric Electrocutaneous Analgesia for Children Experiencing Neuropathic Pain",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07069699",
"publication_url": "https://clinicaltrials.gov/study/NCT07069699",
"title": "Phase 1b/2 Trial of Pidnarulex in MYC Aberrant Lymphoma",
"has_exemption": false,
"start_date": "2026-10-13",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07470164",
"publication_url": "https://clinicaltrials.gov/study/NCT07470164",
"title": "A Randomized Trial of Botulinum Toxin A vs Strabismus Surgery for Esotropia >10 to ≤30PD",
"has_exemption": false,
"start_date": "2027-01-31",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jaeb Center for Health Research",
"sponsor_slug": "jaeb-center-for-health-research",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01754363",
"publication_url": "https://clinicaltrials.gov/study/NCT01754363",
"title": "Short, Medium and Long Term Survivorship of Attune Primary Knee Prosthesis",
"has_exemption": false,
"start_date": "2013-02-01",
"completion_date": "2030-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "DePuy International",
"sponsor_slug": "depuy-international",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06853665",
"publication_url": "https://clinicaltrials.gov/study/NCT06853665",
"title": "A Pharmaco-Imaging Trial of Mixed Amphetamine Salts for the Treatment of ADHD in Intellectually-intact Youth With Autism Spectrum Disorder",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2030-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Gagan Joshi",
"sponsor_slug": "gagan-joshi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07439510",
"publication_url": "https://clinicaltrials.gov/study/NCT07439510",
"title": "A Phase 2b/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SPG601 in Male Participants With Fragile X Syndrome",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2030-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Spinogenix",
"sponsor_slug": "spinogenix",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07061951",
"publication_url": "https://clinicaltrials.gov/study/NCT07061951",
"title": "A Phase 2 Pilot Study of Mirdametinib in Relapsed Refractory Chronic Lymphocytic Leukemia",
"has_exemption": false,
"start_date": "2026-05-27",
"completion_date": "2030-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07313787",
"publication_url": "https://clinicaltrials.gov/study/NCT07313787",
"title": "Prospective Cross-Over Study of the Effects of Meal Macronutrients on Postprandial Lipids",
"has_exemption": false,
"start_date": "2026-06-23",
"completion_date": "2030-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06732388",
"publication_url": "https://clinicaltrials.gov/study/NCT06732388",
"title": "Repurposing Itraconazole for Secondary Prevention of Metaplasia and Primary Prevention of Cancer in Patients With High-Risk Barrett's Esophagus in Combination With Ablation",
"has_exemption": false,
"start_date": "2026-10-06",
"completion_date": "2030-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221357",
"publication_url": "https://clinicaltrials.gov/study/NCT07221357",
"title": "ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2030-02-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06413680",
"publication_url": "https://clinicaltrials.gov/study/NCT06413680",
"title": "A Phase 1/2a, Open-Label, Dose Escalation and Dose Expansion First-In-Human Study of the Safety, Tolerability, Activity, and Pharmacokinetics of REGN10597 (Anti-PD-1-IL-2RA-IL-2 Fusion Protein) Alone or in Combination With Cemiplimab in Patients With Advanced Solid Organ Malignancies",
"has_exemption": false,
"start_date": "2024-09-23",
"completion_date": "2030-02-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07401823",
"publication_url": "https://clinicaltrials.gov/study/NCT07401823",
"title": "An Open-Label Extension Study to Evaluate Long-Term Safety and Tolerability of Pociredir in Participants With Sickle Cell Disease (SCD) Who Have Participated in a Pociredir Study",
"has_exemption": false,
"start_date": "2026-03-30",
"completion_date": "2030-02-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Fulcrum Therapeutics",
"sponsor_slug": "fulcrum-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03309332",
"publication_url": "https://clinicaltrials.gov/study/NCT03309332",
"title": "OSB Lead-AMPLATZER PFO Occluder New Enrollment PAS",
"has_exemption": false,
"start_date": "2018-01-31",
"completion_date": "2030-02-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Abbott Medical Devices",
"sponsor_slug": "abbott-medical-devices",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07486921",
"publication_url": "https://clinicaltrials.gov/study/NCT07486921",
"title": "Etrasimod as Primary and Secondary Prevention of Pouchitis (ESPIRIT)",
"has_exemption": false,
"start_date": "2026-06-12",
"completion_date": "2030-02-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Maia Kayal",
"sponsor_slug": "maia-kayal",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04528082",
"publication_url": "https://clinicaltrials.gov/study/NCT04528082",
"title": "A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study, Followed by an Active Treatment Phase to Evaluate the Efficacy and Safety of Apremilast in Children From 2 to Less Than 18 Years of Age With Active Oral Ulcers Associated With Behçet's Disease (BEAN)",
"has_exemption": false,
"start_date": "2021-09-09",
"completion_date": "2030-02-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04980872",
"publication_url": "https://clinicaltrials.gov/study/NCT04980872",
"title": "A Multicenter, Open-label, Phase 2, Extension Trial to Study the Long-term Safety in Participants With PROS or Proteus Syndrome Who Are Currently Being Treated With Miransertib in Other Studies",
"has_exemption": false,
"start_date": "2021-11-02",
"completion_date": "2030-02-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06799390",
"publication_url": "https://clinicaltrials.gov/study/NCT06799390",
"title": "Vagus Nerve Stimulation Following Intracerebral Hemorrhage (IHC) to Mitigate ICH-induced Inflammation and Cerebral Edema",
"has_exemption": false,
"start_date": "2025-04-06",
"completion_date": "2030-02-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07142343",
"publication_url": "https://clinicaltrials.gov/study/NCT07142343",
"title": "An Open-Label, Single-Arm Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Pozelimab in Pediatric Patients 1 to 5 Years of Age With CD55-Deficient Protein-Losing Enteropathy (CHAPLE Disease)",
"has_exemption": false,
"start_date": "2026-03-19",
"completion_date": "2030-02-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07204249",
"publication_url": "https://clinicaltrials.gov/study/NCT07204249",
"title": "Glutide for Ending Methamphetamine",
"has_exemption": false,
"start_date": "2026-02-26",
"completion_date": "2030-02-15",
"has_results": false,
"results_due": false,
"sponsor_name": "San Francisco Department of Public Health",
"sponsor_slug": "san-francisco-department-of-public-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07539454",
"publication_url": "https://clinicaltrials.gov/study/NCT07539454",
"title": "Phase II Study of Nirogacestat in Patients With Kaposi Sarcoma",
"has_exemption": false,
"start_date": "2026-09-17",
"completion_date": "2030-02-17",
"has_results": false,
"results_due": false,
"sponsor_name": "AIDS Malignancy Consortium",
"sponsor_slug": "aids-malignancy-consortium",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03813407",
"publication_url": "https://clinicaltrials.gov/study/NCT03813407",
"title": "An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia",
"has_exemption": false,
"start_date": "2019-04-02",
"completion_date": "2030-02-21",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07000149",
"publication_url": "https://clinicaltrials.gov/study/NCT07000149",
"title": "A Phase Ib/III Randomized, Multicenter, Global Study of Volrustomig Plus Casdatifan or Volrustomig Monotherapy Versus Nivolumab Plus Ipilimumab as First-line Treatment for Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)",
"has_exemption": false,
"start_date": "2025-07-28",
"completion_date": "2030-02-21",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07497087",
"publication_url": "https://clinicaltrials.gov/study/NCT07497087",
"title": "A Double-blind, Randomised, Placebo-controlled Trial Evaluating the Efficacy and Safety of Oral Nerandomilast Treatment in Patients With Systemic Sclerosis (SSc)",
"has_exemption": false,
"start_date": "2026-06-22",
"completion_date": "2030-02-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04104776",
"publication_url": "https://clinicaltrials.gov/study/NCT04104776",
"title": "A Phase 1/2 Study of DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas",
"has_exemption": false,
"start_date": "2019-09-18",
"completion_date": "2030-02-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00338377",
"publication_url": "https://clinicaltrials.gov/study/NCT00338377",
"title": "Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma",
"has_exemption": false,
"start_date": "2006-02-01",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01966367",
"publication_url": "https://clinicaltrials.gov/study/NCT01966367",
"title": "CD34+ Stem Cell Selection for Patients Receiving a Matched or Partially Matched Family or Unrelated Adult Donor Allogeneic Stem Cell Transplantation for Non-Malignant Disease",
"has_exemption": false,
"start_date": "2013-03-31",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Diane George",
"sponsor_slug": "diane-george",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02912312",
"publication_url": "https://clinicaltrials.gov/study/NCT02912312",
"title": "Shortening Adjuvant Photon Irradiation to Reduce Edema (SAPHIRE): A Randomized Trial of Hypofractionated Versus Conventionally Fractionated Regional Nodal Irradiation for Invasive Breast Cancer",
"has_exemption": false,
"start_date": "2017-02-23",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03424850",
"publication_url": "https://clinicaltrials.gov/study/NCT03424850",
"title": "A Phase I/II Dose-escalation Study Evaluating the Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy",
"has_exemption": false,
"start_date": "2018-02-27",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03726554",
"publication_url": "https://clinicaltrials.gov/study/NCT03726554",
"title": "Comprehensive Reverse Shoulder: Porous Augmented Glenoid Baseplate and Mini Humeral Tray Post-Market Clinical Follow-up Study",
"has_exemption": false,
"start_date": "2018-08-28",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04408352",
"publication_url": "https://clinicaltrials.gov/study/NCT04408352",
"title": "Selective Bladder Denervation Using RF Energy for the Treatment of UUI",
"has_exemption": false,
"start_date": "2020-04-27",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Hologic, Inc.",
"sponsor_slug": "hologic-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04989803",
"publication_url": "https://clinicaltrials.gov/study/NCT04989803",
"title": "A Phase 1/2 Open-label, Multicenter Study Evaluating the Safety and Efficacy of KITE-363 or KITE-753, Autologous Anti-CD19/CD20 CAR T-cell Therapies, in Subjects With Relapsed and/or Refractory B-cell Lymphoma",
"has_exemption": false,
"start_date": "2021-10-27",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Kite, A Gilead Company",
"sponsor_slug": "kite-a-gilead-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06528314",
"publication_url": "https://clinicaltrials.gov/study/NCT06528314",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH",
"has_exemption": false,
"start_date": "2024-09-04",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Akero Therapeutics, Inc",
"sponsor_slug": "akero-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06433635",
"publication_url": "https://clinicaltrials.gov/study/NCT06433635",
"title": "Sequential Multiple Assignment Randomized Trial for Bipolar Depression",
"has_exemption": false,
"start_date": "2024-10-01",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06895785",
"publication_url": "https://clinicaltrials.gov/study/NCT06895785",
"title": "Exalt Single-use Duodenoscope Vs Reusable Scope, a Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-02-21",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Rush University Medical Center",
"sponsor_slug": "rush-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06839976",
"publication_url": "https://clinicaltrials.gov/study/NCT06839976",
"title": "CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Adolescents and Young Adults With Systemic Lupus Erythematosus (SLE)",
"has_exemption": false,
"start_date": "2025-05-06",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital of Philadelphia",
"sponsor_slug": "childrens-hospital-of-philadelphia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06919666",
"publication_url": "https://clinicaltrials.gov/study/NCT06919666",
"title": "Phase Ib/II Study of NT219 in Combination With Pembrolizumab or Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)",
"has_exemption": false,
"start_date": "2025-06-12",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06903923",
"publication_url": "https://clinicaltrials.gov/study/NCT06903923",
"title": "Bone Metabolism in Adolescents Undergoing GLP-1 Receptor Agonist Therapy",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Virginia",
"sponsor_slug": "university-of-virginia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07003997",
"publication_url": "https://clinicaltrials.gov/study/NCT07003997",
"title": "Janus Kinase (JAK) Signaling in Depression",
"has_exemption": false,
"start_date": "2025-09-03",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07278505",
"publication_url": "https://clinicaltrials.gov/study/NCT07278505",
"title": "Pathophysiological Mechanisms of Cannabidiol in Stress Regulation",
"has_exemption": false,
"start_date": "2025-10-28",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06990269",
"publication_url": "https://clinicaltrials.gov/study/NCT06990269",
"title": "A Phase 2, Randomized, Masked, Placebo-Controlled Study of Subcutaneously Administered ADX-038 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)",
"has_exemption": false,
"start_date": "2025-11-10",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "ADARx Pharmaceuticals, Inc.",
"sponsor_slug": "adarx-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06890338",
"publication_url": "https://clinicaltrials.gov/study/NCT06890338",
"title": "A Single-Arm, Phase 2 Study of Neoadjuvant Carboplatin and Mirvetuximab Soravtansine in Subjects With FRα-Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer",
"has_exemption": false,
"start_date": "2025-11-21",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06686771",
"publication_url": "https://clinicaltrials.gov/study/NCT06686771",
"title": "Consolidative Use of Radiotherapy to Block (CURB2) Oligoprogression In Patients With Metastatic Non-Small-Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-12-16",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Canadian Cancer Trials Group",
"sponsor_slug": "canadian-cancer-trials-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07278557",
"publication_url": "https://clinicaltrials.gov/study/NCT07278557",
"title": "Assessment of Sparing Parotid Ducts Via MRI Sialography for Reduced Patient-Reported Xerostomia Following Radiotherapy for Oropharynx Cancer",
"has_exemption": false,
"start_date": "2026-01-28",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "UNC Lineberger Comprehensive Cancer Center",
"sponsor_slug": "unc-lineberger-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06625190",
"publication_url": "https://clinicaltrials.gov/study/NCT06625190",
"title": "Allogeneic Stem Cell Transplantation Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion With Zoledronic Acid in Combination to Treat Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory Solid Tumors",
"has_exemption": false,
"start_date": "2026-02-11",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07318480",
"publication_url": "https://clinicaltrials.gov/study/NCT07318480",
"title": "Cognitively-enhanced tDCS of the Dorsolateral Prefrontal Cortex to Reduce Craving in Cocaine Addiction",
"has_exemption": false,
"start_date": "2026-02-25",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07290621",
"publication_url": "https://clinicaltrials.gov/study/NCT07290621",
"title": "Phase II Trial of Neoadjuvant Toripalimab in Combination With Chemotherapy Followed by Transoral Robotic Surgery or Risk/Response Stratified Chemoradiotherapy for Locoregional HPV16+ Oropharyngeal Cancer: TARGET HPV Cohort 2",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07300956",
"publication_url": "https://clinicaltrials.gov/study/NCT07300956",
"title": "Comparing Medication Treatments for Neurodevelopmental Differences in Young Children on Rates of Beneficial Response",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Medical Center, Cincinnati",
"sponsor_slug": "childrens-hospital-medical-center-cincinnati",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06871488",
"publication_url": "https://clinicaltrials.gov/study/NCT06871488",
"title": "Identification of Neural Markers of Aggression and Irritability and Their Capacity to Predict Treatment Response to CNS Stimulant Medication in Youth With ADHD",
"has_exemption": false,
"start_date": "2026-03-05",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Milton S. Hershey Medical Center",
"sponsor_slug": "milton-s-hershey-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07459647",
"publication_url": "https://clinicaltrials.gov/study/NCT07459647",
"title": "An Open-Label Study to Assess the Long-Term Safety, Tolerability, and Effectiveness of ML-007C-MA in Adult Participants With Schizophrenia",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "MapLight Therapeutics",
"sponsor_slug": "maplight-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07318714",
"publication_url": "https://clinicaltrials.gov/study/NCT07318714",
"title": "A Phase 1/2 Multicenter, Open-label, Dose Escalation Study Followed by a Randomized, Double-blind Sham-controlled Dose Expansion Study to Evaluate the Safety, Tolerability and Efficacy of ASP2246 in Adult Participants Who Have Motor Dysfunction Associated With Late Subacute to Chronic Ischemic Stroke Due to Supratentorial Perforator Area Infarction",
"has_exemption": false,
"start_date": "2026-04-03",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Astellas Pharma Inc",
"sponsor_slug": "astellas-pharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07226869",
"publication_url": "https://clinicaltrials.gov/study/NCT07226869",
"title": "Computer Guided Microwave Liver Ablation",
"has_exemption": false,
"start_date": "2026-05-08",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "NE Scientific INC",
"sponsor_slug": "ne-scientific-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07166393",
"publication_url": "https://clinicaltrials.gov/study/NCT07166393",
"title": "Multi-institutional Phase 2/3 Trial of Valproic Acid in Patients With Moderate to Severe Traumatic Brain Injury",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06824649",
"publication_url": "https://clinicaltrials.gov/study/NCT06824649",
"title": "SMART Use of Biologics in Chronic Rhinosinusitis With Nasal Polyposis",
"has_exemption": false,
"start_date": "2026-06-03",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07588568",
"publication_url": "https://clinicaltrials.gov/study/NCT07588568",
"title": "A Trial of Upadacitinib for Non-responsive Eosinophilic Esophagitis (ATUNE)",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of North Carolina, Chapel Hill",
"sponsor_slug": "university-of-north-carolina-chapel-hill",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07601295",
"publication_url": "https://clinicaltrials.gov/study/NCT07601295",
"title": "A Phase II, Randomized, Double-Blind, Safety and Efficacy Study of Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07460375",
"publication_url": "https://clinicaltrials.gov/study/NCT07460375",
"title": "A First-in-Human Phase 1/2, Dose Escalation and Dose Expansion Study to Evaluate Safety, Tolerability, and Preliminary Efficacy of Claudin18.2 (CLDN18.2)-Directed Antibody-Drug Conjugate (ADC) LCB02A in Patients With CLDN18.2-positive Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "LigaChem Biosciences, Inc.",
"sponsor_slug": "ligachem-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07129759",
"publication_url": "https://clinicaltrials.gov/study/NCT07129759",
"title": "A Long-term Extension Study to Evaluate the Safety and Tolerability of Daily Oral LUM-201 in Children With Growth Hormone Deficiency (GHD)",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Lumos Pharma",
"sponsor_slug": "lumos-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06315322",
"publication_url": "https://clinicaltrials.gov/study/NCT06315322",
"title": "A MULTICENTER, OPEN-LABEL, SINGLE-ARM STUDY TO EVALUATE LONG-TERM SAFETY AND TOLERABILITY OF BRIVARACETAM IN STUDY PARTICIPANTS WITH CHILDHOOD ABSENCE EPILEPSY OR JUVENILE ABSENCE EPILEPSY",
"has_exemption": false,
"start_date": "2024-07-10",
"completion_date": "2030-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "UCB Biopharma SRL",
"sponsor_slug": "ucb-biopharma-srl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06532123",
"publication_url": "https://clinicaltrials.gov/study/NCT06532123",
"title": "Mechanisms of Improving Fecal Continence Muscles Motor Function in Health and Disease",
"has_exemption": false,
"start_date": "2025-07-15",
"completion_date": "2030-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04774536",
"publication_url": "https://clinicaltrials.gov/study/NCT04774536",
"title": "Transplantation of CRISPRCas9 Corrected Hematopoietic Stem Cells (CRISPR_SCD001) in Patients With Severe Sickle Cell Disease",
"has_exemption": false,
"start_date": "2025-08-22",
"completion_date": "2030-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mark Walters, MD",
"sponsor_slug": "mark-walters-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07591649",
"publication_url": "https://clinicaltrials.gov/study/NCT07591649",
"title": "Safety and Efficacy of Expanded KIR-HLA Mismatched Natural Killer Cell Immunotherapy (AdaptNK) for High-Risk Myeloid Diseases as Bridge to Allogeneic Hematopoietic Stem Cell Transplantation",
"has_exemption": false,
"start_date": "2026-05-08",
"completion_date": "2030-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Masonic Cancer Center, University of Minnesota",
"sponsor_slug": "masonic-cancer-center-university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07382596",
"publication_url": "https://clinicaltrials.gov/study/NCT07382596",
"title": "Cervical Plexus Hydrodissection With D5W Versus NS for Treatment-Resistant PTSD",
"has_exemption": false,
"start_date": "2026-05-16",
"completion_date": "2030-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Dr. Dean Reeves Clinic",
"sponsor_slug": "dr-dean-reeves-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06965114",
"publication_url": "https://clinicaltrials.gov/study/NCT06965114",
"title": "A Phase 1 Study of Combination Tovorafenib (DAY101) and Rituximab Treatment in Relapsed or Refractory Classical Hairy Cell Leukemia and Phase 2 Randomized Study Comparing Tovorafenib (DAY101) and Rituximab With Cladribine and Rituximab for Front-Line Treatment of Classical Hairy Cell Leukemia",
"has_exemption": false,
"start_date": "2026-05-29",
"completion_date": "2030-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05713799",
"publication_url": "https://clinicaltrials.gov/study/NCT05713799",
"title": "Phase II Trial of the Combination of Alpha-lipoic Acid and Mirabegron in Women and in Men With Obesity",
"has_exemption": false,
"start_date": "2026-06-23",
"completion_date": "2030-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07526545",
"publication_url": "https://clinicaltrials.gov/study/NCT07526545",
"title": "UPRISE (Urine Prostate Screening Integrated With MRI for Prostate Cancer Early Detection)",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2030-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan Rogel Cancer Center",
"sponsor_slug": "university-of-michigan-rogel-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04200729",
"publication_url": "https://clinicaltrials.gov/study/NCT04200729",
"title": "Povidone-iodine Irrigation for Prevention of Intra-abdominal Abscess in Pediatric Perforated Appendicitis",
"has_exemption": false,
"start_date": "2027-03-01",
"completion_date": "2030-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05215340",
"publication_url": "https://clinicaltrials.gov/study/NCT05215340",
"title": "A Randomized, Open-label, Phase 3 Trial of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in Treatment-naïve Subjects With Advanced or Metastatic PD-L1 High (TPS ≥50%) Non-small Cell Lung Cancer Without Actionable Genomic Alterations (TROPION-Lung08)",
"has_exemption": false,
"start_date": "2022-03-04",
"completion_date": "2030-03-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05952557",
"publication_url": "https://clinicaltrials.gov/study/NCT05952557",
"title": "CAMBRIA-2: A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant (AZD9833, a Next Generation, Oral Selective Estrogen Receptor Degrader) vs Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) as Adjuvant Treatment for Patients With ER+/HER2- Early Breast Cancer and an Intermediate-High or High Risk of Recurrence Who Have Completed Definitive Locoregional Treatment and Have No Evidence of Disease",
"has_exemption": false,
"start_date": "2023-10-05",
"completion_date": "2030-03-04",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07459673",
"publication_url": "https://clinicaltrials.gov/study/NCT07459673",
"title": "HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission",
"has_exemption": false,
"start_date": "2026-03-04",
"completion_date": "2030-03-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06899126",
"publication_url": "https://clinicaltrials.gov/study/NCT06899126",
"title": "A Phase 3, Multicenter, Randomized, Open-label Trial of Trastuzumab Deruxtecan in Combination With Pembrolizumab Versus Platinum-based Chemotherapy in Combination With Pembrolizumab, as First-line Therapy in Participants With Locally Advanced Unresectable or Metastatic HER2 Overexpressing and PD-L1 TPS <50% Non-squamous Non-small Cell Lung Cancer (DESTINY-Lung06)",
"has_exemption": false,
"start_date": "2025-10-24",
"completion_date": "2030-03-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03148418",
"publication_url": "https://clinicaltrials.gov/study/NCT03148418",
"title": "An Open-Label, Multicenter Extension and Long-Term Observational Study in Patients Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study",
"has_exemption": false,
"start_date": "2017-09-20",
"completion_date": "2030-03-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06869551",
"publication_url": "https://clinicaltrials.gov/study/NCT06869551",
"title": "A Phase 3, Multicenter, Double-blind, Placebo-controlled, Randomized Withdrawal Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Deucravacitinib in Children and Adolescents From 5 to Less Than 18 Years of Age With Active Juvenile Psoriatic Arthritis",
"has_exemption": false,
"start_date": "2025-03-13",
"completion_date": "2030-03-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05837897",
"publication_url": "https://clinicaltrials.gov/study/NCT05837897",
"title": "A Phase 3, Multicenter, Randomized, Parallel-Group, Double-blind, Placebo-Controlled Induction Study Followed by an Open-label Extension Period to Evaluate the Efficacy and Safety of Intravenous Vedolizumab (300 mg) Infusion Treatment in Subjects in China With Moderately to Severely Active Crohn's Disease",
"has_exemption": false,
"start_date": "2023-06-16",
"completion_date": "2030-03-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07424404",
"publication_url": "https://clinicaltrials.gov/study/NCT07424404",
"title": "A Phase 3 Multicenter, Open-label Study to Assess the Long-term Safety and Tolerability of KarXT in Adolescents (13 to 17 Years of Age) With Schizophrenia and KarXT+KarX-EC in Children and Adolescents (5 to 17 Years of Age) With Irritability Associated With Autism Spectrum Disorder",
"has_exemption": false,
"start_date": "2026-04-07",
"completion_date": "2030-03-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Karuna Therapeutics, Inc., a Bristol Myers Squibb company",
"sponsor_slug": "karuna-therapeutics-inc-a-bristol-myers-squibb-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05785767",
"publication_url": "https://clinicaltrials.gov/study/NCT05785767",
"title": "A Randomized, Double-Blind Phase 2/3 Study of Fianlimab (Anti-LAG-3 Antibody) in Combination With Cemiplimab (Anti-PD-1 Antibody) Versus Cemiplimab Monotherapy in First-Line Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) With Tumors Expressing PD-L1 ≥50%",
"has_exemption": false,
"start_date": "2023-06-30",
"completion_date": "2030-03-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05646381",
"publication_url": "https://clinicaltrials.gov/study/NCT05646381",
"title": "A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis [Lp(a)FRONTIERS CAVS]",
"has_exemption": false,
"start_date": "2024-03-07",
"completion_date": "2030-03-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07483307",
"publication_url": "https://clinicaltrials.gov/study/NCT07483307",
"title": "Impact of Neoadjuvant Endocrine Therapy on Surgical Outcomes in Patients With Stage 2 to 3 Invasive Lobular Carcinoma: A Prospective Study",
"has_exemption": false,
"start_date": "2026-03-13",
"completion_date": "2030-03-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06987539",
"publication_url": "https://clinicaltrials.gov/study/NCT06987539",
"title": "A Phase 2 Open-label Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children From 2 Years to Less Than 18 Years of Age With Generalized Myasthenia Gravis (gMG)",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2030-03-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06565507",
"publication_url": "https://clinicaltrials.gov/study/NCT06565507",
"title": "A Double-blind Multicenter, Randomized Controlled Trial of Single and Multiple Dose Regimens of Oxfendazole for Mild (One or Two Lesions) Parenchymal Brain Cysticercosis, With an Open Comparison Group",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2030-03-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Universidad Peruana Cayetano Heredia",
"sponsor_slug": "universidad-peruana-cayetano-heredia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05691478",
"publication_url": "https://clinicaltrials.gov/study/NCT05691478",
"title": "A Feasibility and Randomized Phase 2/3 Study of the VEGFR2/MET Inhibitor Cabozantinib in Combination With Cytotoxic Chemotherapy for Newly Diagnosed Osteosarcoma",
"has_exemption": false,
"start_date": "2023-03-03",
"completion_date": "2030-03-20",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06042569",
"publication_url": "https://clinicaltrials.gov/study/NCT06042569",
"title": "Dose Reduction of Docetaxel-Based Chemotherapy in Vulnerable Older Women With Early-Stage Breast Cancer (DOROTHY)",
"has_exemption": false,
"start_date": "2024-09-16",
"completion_date": "2030-03-20",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07178301",
"publication_url": "https://clinicaltrials.gov/study/NCT07178301",
"title": "Elective Neck Dosing in Low Risk Oropharyngeal Human Papillomavirus-Related Cancer Treatment (ENLIGHT): A Single Arm Prospective Phase II Assessing 30 Gy Elective Neck Dose",
"has_exemption": false,
"start_date": "2025-12-05",
"completion_date": "2030-03-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07253285",
"publication_url": "https://clinicaltrials.gov/study/NCT07253285",
"title": "Efficacy, Safety and Pharmacokinetics of Cagrilintide s.c. 2.4 mg as Monotherapy and in Combination With Semaglutide s.c. 2.4 mg (CagriSema) Once Weekly for Weight Management in Chidren and Adolescents With Overweight or Obesity",
"has_exemption": false,
"start_date": "2026-01-08",
"completion_date": "2030-03-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05753306",
"publication_url": "https://clinicaltrials.gov/study/NCT05753306",
"title": "A Phase II Study of Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients With Gastric Cancer and Limited Peritoneal Metastasis: ROBO-CHIP Trial",
"has_exemption": false,
"start_date": "2023-04-20",
"completion_date": "2030-03-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06347055",
"publication_url": "https://clinicaltrials.gov/study/NCT06347055",
"title": "Neuronavigated Non-invasive Brain Stimulation for Nicotine Dependence.",
"has_exemption": false,
"start_date": "2024-10-01",
"completion_date": "2030-03-25",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Missouri-Columbia",
"sponsor_slug": "university-of-missouri-columbia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05125016",
"publication_url": "https://clinicaltrials.gov/study/NCT05125016",
"title": "Phase 1/2 Study of REGN4336 (a PSMAxCD3 Bispecific Antibody) Administered Alone or in Combination With REGN5678 (a PSMAxCD28 Bispecific Antibody) in Patients With Metastatic Castration-Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2021-11-30",
"completion_date": "2030-03-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05352919",
"publication_url": "https://clinicaltrials.gov/study/NCT05352919",
"title": "A Multicenter, Randomized, Dose-Blind, Phase 3 Long-Term Extension Study to Evaluate Continuous Safety and Efficacy of Litifilimab (BIIB059) in Adult Participants With Active Systemic Lupus Erythematosus",
"has_exemption": false,
"start_date": "2022-06-10",
"completion_date": "2030-03-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Biogen",
"sponsor_slug": "biogen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07222800",
"publication_url": "https://clinicaltrials.gov/study/NCT07222800",
"title": "AN INTERVENTIONAL, PHASE 3, DOUBLE-BLIND, RANDOMIZED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY VERSUS BEVACIZUMAB IN COMBINATION WITH CHEMOTHERAPY IN TREATMENT-NAÏVE PARTICIPANTS WITH METASTATIC COLORECTAL CANCER",
"has_exemption": false,
"start_date": "2025-12-11",
"completion_date": "2030-03-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07446855",
"publication_url": "https://clinicaltrials.gov/study/NCT07446855",
"title": "A Modular Open-label, Phase I/IIa Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of Ascending Doses of AZD4956 as Monotherapy, and in Combination With Anti-Cancer Agents in Participants With Advanced/Metastatic Homologous Recombination Repair Defective Solid Tumours",
"has_exemption": false,
"start_date": "2026-03-17",
"completion_date": "2030-03-29",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}